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Summary
Substantial advances in Bayesian methods for causal inference have been made in
recent years. We provide an introduction to Bayesian inference for causal effects
for practicing statisticians who have some familiarity with Bayesian models and
would like an overview of what it can add to causal estimation in practical set-
tings. In the paper, we demonstrate how priors can induce shrinkage and sparsity in
parametric models and be used to perform probabilistic sensitivity analyses around
causal assumptions. We provide an overview of nonparametric Bayesian estima-
tion and survey their applications in the causal inference literature. Inference in the
point-treatment and time-varying treatment settings are considered. For the latter, we
explore both static and dynamic treatment regimes. Throughout, we illustrate imple-
mentation using off-the-shelf open source software. We hope to leave the reader with
implementation-level knowledge of Bayesian causal inference using both parametric
and nonparametric models. All synthetic examples and code used in the paper are
publicly available on a companion GitHub repository.
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1 INTRODUCTION
Causal inference is broadly concerned with estimating parameters governing the causal mechanisms between an intervention or
treatment of interest and an outcome. These causal parameters can differ substantially from associational ones. Causal inference
provides a framework for 1) constructing different estimands that have explicitly causal, rather than associational, interpretations
2) formulating the assumptions under which we can estimate these using observed data, 3) devising sensitivity analyses around
violations of these assumptions, and 4) making inferences about these causal estimands via statistical modeling. These are just
some of the many contributions of the causal inference literature, which we will touch on throughout this paper.
Bayesian modeling in causal inference has been growing in popularity. There are perhaps several reasons for this phenomenon.
First, Bayesian modeling yields full posterior inference for any function of model parameters. For instance, point and interval
estimates can be easily constructed for causal risk ratios, odds ratios, and risk differences by post-processing a single set of
posterior draws from logistic regression model. Another advantage is the use of priors to induce shrinkage and sparsity in
causal models - yielding more regularized causal effect estimates. We show that these can be more satisfying than the ad-hoc
alternatives often employed. Priors can also be used to conduct probabilistic sensitivity analyses around violations of key causal
identification assumptions. Finally, the Bayesian literature consists of a large suite of nonparametric models that can be readily
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2 Oganisian ET AL
applied to causal modeling. These nonparametric approaches are appealing because, unlike many classical machine learning
algorithms, they allow for posterior uncertainty estimation as well as robust point estimates.
We begin with an overview of the causal identification and the Bayesian linear model before moving to confounder adjust-
ment via standardization in the point-treatment setting. Here we highlight how priors can be used to induce shrinkage in a causal
dose effect curve and partially pool conditional average treatment effect estimates across sparsely populated subgroups. Par-
tial pooling shrinks the heterogeneous effects across subgroups towards an overall homogenous effect in the absence of data.
We introduce the Bayesian bootstrap as a method for performing standardization. Next, we move to the time-varying treatment
and confounding setting where we discuss Bayesian 푔-computation with priors that promote sparsity. Causal inference in these
settings requires estimation of a large number of nuisance parameters. Priors that regularize these estimates by encouraging
sparsity can be an attractive alternative to common modeling assumptions, which can be quite strict. Estimation for both static
and dynamic treatment regimes are discussed. We then turn to using priors for causal sensitivity analyses. These follow from
expressing violations of causal assumptions in terms of non-identifiable parameters, then conveying uncertainty about the mag-
nitude/direction of the violation via priors on these parameters. We end with a discussion of Bayesian nonparametric causal
estimation. We discuss Dirichlet process priors, Bayesian Additive Regression Trees, Gaussian processes and survey their appli-
cations to causal problems. Throughout, we present several pedagogical examples using publicly available synthetic data. We
hope to demonstrate how readily these models can be implemented using existing software. A companion GitHub3 repository
contains all relevant implementation code that reproduce the results in this paper.
2 INGREDIENTS OF BAYESIAN CAUSAL INFERENCE
2.1 Causal Estimands and Identification Assumptions
In order to make causal inferences, we first need to define and identify the causal estimand. After doing so, we will turn to
the statistical problem of actually making inferences about this estimand. Consider estimation of the causal effect of a binary
treatment assignment 퐴 ∈ {0, 1} on some observed scalar outcome 푌 . In this paper, we formulate estimands in terms of
potential outcome 푌 푎 1. This represents the outcome that would have been observed had a subject received treatment 퐴 = 푎.
For subjects receiving treatment 퐴 = 푎, we never observe their counterfactual outcome, 푌 1−푎. If we did observe both potential
outcomes, we could estimate each subject’s individual-level effects by taking the difference 푌 1 − 푌 0. This is the difference in
outcome had the subject taken treatment 1 versus 0. We could also estimate a population-level average treatment effect (ATE),
Ψ = 퐸[푌 1] − 퐸[푌 0], directly by simply taking the sample average of the difference, 푌 1 − 푌 0, across all subjects. The ATE is
interpreted as the average difference in the outcome had everyone in the target population received treatment 퐴 = 1 rather than
퐴 = 0. In absence of the counterfactual, we cannot estimate the individual-level effects and can only estimate Ψ under certain
identification assumptions (퐼퐴s).
To understand the role of these assumptions, it is helpful to consider the data we actually observe. Along with 푌 (note the
lack of superscript) and 퐴, we observe a vector of confounders 퐿 - these are variables, measured pre-treatment, that impact
both treatment assignment and outcome. Thus, we could estimate the conditional outcome mean, or regression, 퐸[푌 ∣ 퐴,퐿]
directly from observed data. The aforementioned identification assumptions are required to expressΨ - the difference in average
unobserved potential outcomes - in terms of 퐸[푌 ∣ 퐴 = 1, 퐿]−퐸[푌 ∣ 퐴 = 0, 퐿] - the average difference in conditional outcome
means between the two treatment groups. Identification refers precisely to this process of expressing (“identifying”) estimands
such as Ψ in terms of observed data. In this setting with a single baseline treatment, the standard 퐼퐴s2 are
퐼퐴.1: Conditional ignorability: 푌 푎 ⟂ 퐴 ∣ 퐿.
퐼퐴.2: Consistency: 푃 (푌 푎 = 푌 ∣ 퐴 = 푎) = 1, ∀푎.
퐼퐴.3: No interference: 푌 푎1∶푛푖 = 푌 푎푖푖 .
퐼퐴.4: Positivity: 0 < 푃 (퐴 = 1 ∣ 퐿) < 1, ∀퐿 ∈ .
Above, 푎1∶푛 = (푎1, 푎2,… , 푎푖,… , 푎푛) is a vector of treatment interventions for each of 푛 observed subjects and 푌 푎1∶푛푖 representssubject 푖’s potential outcome had each subject received their corresponding treatments in 푎1∶푛. 퐼퐴.1 requires that pre-treatment
3https://github.com/stablemarkets/intro_bayesian_causal
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variables 퐿 fully capture the confounding between treatment and outcome. That is, conditioning on 퐿 renders the potential
outcome under a particular treatment, 푌 푎, independent of the observed treatment assignment, 퐴. This can be violated if, for
instance, we fail to condition on some confounder, such as age, when in fact older subjects tend to be treated with treatment
퐴 = 1 and are likely to have worse outcomes under this treatment, 푌 1. It is important to note that conditioning on inappropriate
variables (e.g. colliders or post-treatment variables) may also lead to ignorability violations3. In this paper, we will discuss ways
to perform sensitivity analyses around violations of this assumption.
Consistency, 퐼퐴.2, requires that the treatment be well-defined in terms of a clear intervention4. For example, suppose 퐴 is
high/low blood pressure and 푌 is myocardial infarction. The outcome that occurs in a world where we intervene directly to lower
blood pressure is likely not the outcome that would have occurred had everyone in the population had low blood pressure. This is
because the mechanism by which we set blood pressure likely itself affects the outcome. Whether blood pressured was lowered
via changes in lifestyle (exercise, better eating habits, etc) versus medication probably impacts the outcome. For this reason,
consistency is often described as requiring that there is only “one version” of the treatment. A more well-defined intervention
may be blood pressure medication use (versus no use). Other canonical examples of ill-defined exposures include race and BMI5.
퐼퐴.3 states that no subject’s treatment assignment should affect another’s potential outcome. Formally, the 푖푡ℎ subject’s poten-
tial outcome under intervention 퐴푖 = 푎, 푌 푎푖푖 , need not be indexed by the other 푛 − 1 subjects’ interventions in the superscript.Hence, we can simplify 푌 푎1∶푛푖 to just 푌 푎푖푖 . This assumption is often violated if subjects are not independent. For example, a studyof the effect of prophylactic antivirals on infection using data from patients in the same hospital may suffer from interference:
the antiviral treatment of subjects roomed together affect each other’s infection probability. For concreteness, consider two such
patients, 푖 and 푗, with potential infection status, 푌 푎푖,푎푗푖 and 푌 푎푖,푎푗푗 , respectively. Here, intervention 푎 = 1 indicates antiviral ther-
apy and 푎 = 0 indicates control. If the infection is contagious, it may be the case that 푃 (푌 0,1푖 ) < 푃 (푌 0,0푖 ). Even if subject 푖 isuntreated, their infection probability would likely be lower had their neighbor, subject 푗, been treated. Since we cannot speak of
subject 푖’s outcome separately from subject 푗’s treatment, we cannot drop 푎푗 from the superscript in 푌 푎푖,푎푗푖 . Causal inference inthese settings is more complicated and an active area of research6.
Finally, 퐼퐴.4 requires that the treatment probability be bounded so that there is no subset of the population in terms of 퐿
for whom treatment is deterministic. Intuitively, if treatment assignment was deterministic for a subpopulation of individuals,
we would have no data about that group’s outcome under the other treatment condition. Positivity violations can occur at the
population level (e.g. protocols forbidding treatment 푎 for subjects over a certain age) or at the sample level due to small sample
size (e.g. we observe no male diabetics with treatment 푎). The former are sometimes called structural violations and the latter
are called random violations of positivity in the literature.
Using these assumptions we can identify both expectations in Ψ. First, under 퐼퐴.3, 퐸[푌 푎1∶푛푖 ] = 퐸[푌 푎푖푖 ]. Omitting subscriptsfor compactness,
퐸[푌 푎] = ∫
퐸[푌 푎 ∣ 퐿] 푑푃 (퐿)
= ∫
퐸[푌 푎 ∣ 퐴 = 푎, 퐿] 푑푃 (퐿)
= ∫
퐸[푌 ∣ 퐴 = 푎, 퐿] 푑푃 (퐿)
(1)
The first equality follows from iterated expectation over 퐿. We use  to denote the space of 퐿. From 퐼퐴.1, we know that the
potential outcome is independent of assignment conditional on 퐿, which allows us to condition on 퐴 = 푎 in the second equality.
퐼퐴.4 ensures that we are not conditioning on a zero-probability event. Lastly, 퐼퐴.2 allows us to drop the superscript. Intuitively,
(1) identifies the average potential outcome as a regression model (under intervention 퐴 = 푎) that is averaged over the marginal
confounder distribution. Computing marginal causal effect using this expression is called standardization. In this way, we have
identified each term of Ψ in terms a regression that is estimable from observed data.
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2.2 Statistical Assumptions
Equation (1) usually requires statistical/modeling assumptions about the regression, 퐸[푌 ∣ 퐴,퐿]. As an example, consider
substituting a linear regression model 퐸[푌 ∣ 퐴,퐿] = 휃퐴 + 퐿′훽 (where an intercept is included in 퐿). Then, under the 퐼퐴s,
standardization yields
Ψ = ∫
퐸[푌 ∣ 퐴 = 1, 퐿, 휔] − 퐸[푌 ∣ 퐴 = 0, 퐿, 휔]푑푃 (퐿)
= ∫
{(휃 + 퐿′푖훽) − (퐿
′
푖훽)}푑푃 (퐿) = 휃.
(2)
In this special case, the ATE, Ψ, is equal to the treatment indicator coefficient, 휃. Thus, an estimate of this coefficient is an
estimate of the ATE. In the non-linear examples discussed later, 퐿′푖훽 will not cancel out as it did above and a probability modelfor 푝(퐿) will be necessary to evaluate the integral.
2.3 Bayesian Modeling
Bayesian causal inference combines Bayesian modeling with the 퐼퐴s discussed to compute a posterior distribution over causal
estimands. In this section we introduce these key ideas, which will be expanded in future sections. Throughout much of the
paper, we assume that 퐼퐴s hold to keep focus on the added benefit of Bayesian modeling.
Supposewe observe data퐷 = {푌푖, 퐴푖, 퐿푖}푖=1∶푛 on 푛 independent subjects, where퐴푖 ∈ {0, 1} is a binary treatment indicator,퐿푖
is a vector of confounders (including an intercept), and 푌푖 is the scalar outcome of interest, as defined earlier. Bayesian inference
requires both a probability model for the conditional distribution of the outcome, 푌 , (a likelihood) as well as a probability
distribution over the unknown parameter vector, 휔, governing this conditional distribution (i.e. a prior). Inference then follows
from making probability statements about 휔 having conditioned on 퐷 (via the posterior). From Bayes’ rule we have that the
posterior is proportional to the likelihood times the prior, 푝(휔 ∣ 퐷) ∝ 푝(휔)∏푖 푝(푌푖 ∣ 퐴푖, 퐿푖, 휔).
For instance, if 푌푖 is real-valued, we could specify a Gaussian outcome model with conditional mean 휃퐴푖 +퐿′푖훽 and variance
휙: 푝(푌푖 ∣ 퐴푖, 퐿푖, 휔) = 푁(푌푖 ∣ 휃퐴푖 + 퐿′푖훽, 휙). We could also set a Normal-Inverse-Gamma prior on the parameter vector
휔 = (휃, 훽, 휙), e.g. 푝(휔) = 푁(휃 ∣ 0, 1)푁(훽 ∣ 휇0,Σ0)퐼퐺(휙 ∣ 푎0, 푏0). This probability model induces a linear regression 퐸[푌 ∣
퐴푖, 퐿푖] = 휃퐴푖+퐿′푖훽, where we drop explicit conditioning on the parameters. Now it remains to find the posterior over the modelparameters, 푝(휔 ∣ 퐷) - which includes 휃. As we showed with the linear model in the previous section, the coefficient 휃 is the
ATE, Ψ. So a posterior over 휃 is a posterior over Ψ. This simple example demonstrates a general Bayesian approach to causal
inference. First, identify the causal parameter of interest as a transformation of themodel parameters. The 퐼퐴s required to achieve
this will vary by problem and strategy. Mediation7 and time-varying treatment8 settings will require extensions of the 퐼퐴s
discussed. Instrumental variables9, difference-in-differences10, and regression discontinuity11 strategies all involve their own
unique 퐼퐴s. Second, obtain the posterior distribution (or draws from it) of these model parameters which, after transformation,
yields a posterior over the causal estimand.
In practical settings, the posterior distribution, 푝(휔 ∣ 퐷) does not have known form - so that we cannot analytically find the
posterior after specifying the likelihood and prior. As a result, inference is instead typically conducted using draws from the
posterior obtained via Markov Chain Monte Carlo (MCMC). Though a crucial topic and active area of research in itself, we omit
discussion of MCMC methods and keep focus on Bayesian estimation of causal effects. We refer the reader to Andrieu et al.12
for an introduction to MCMC. For our purposes, it is enough to know that MCMC yields a set of푀 draws, {휔(푚)}1∶푀 , from the
posterior 푝(휔 ∣ 퐷) given a specified likelihood and prior. Throughout, we assume we have sufficiently many draws to closely
approximate the posterior. The mean or median of these samples can be used as a Bayesian point estimate of 휔. Percentiles of
these draws can be used for credible interval estimation (e.g. .025 and .975 percentiles for a 95% interval).
This paper relies mainly on Stan for MCMC sampling throughout. Stan is an open-source programming language for spec-
ifying Bayesian models using intuitive syntax. It back-ends to C++ to efficiently obtain posterior draws after a likelihood and
prior are specified. Stan programs are often called inR via the package rstan. For those unfamiliar with Stan andR, we provide
some guidance with SAS version 9.4 - a popular commercial statistical analysis software. Some of the nonparametric models to
be discussed cannot be handled in either Stan or SAS. For these models, we will rely on specialized R packages.
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(a) Posterior estimates from (3) with prior (4) with 퐾 = 10,
휇1 = 0, 휏1 = 10, and 휏푘 = 1 for all 푘. The AR1 prior smooths
erratic MLEs by inducing correlation between neighboring
points on the curve.
(b) Posterior estimates of Ψ(푣) from (6) with partial pooling
prior of Section 3.2 with 푞 = 5, a single confounder 푊 , an
improper uniform prior on 휇, and 휏 = .5. Posterior mean odds
ratio for each stratum are shrunk towards the overall causal
odds ratio (dotted line).
FIGURE 1 Estimates of dose effect curve (Section 3.1) and partially pooled conditional causal odds ratios (Section 3.2) using
synthetic data.
2.4 Prior Information
As mentioned earlier, Bayesian inference requires specification of a prior over the parameters, 푝(휔). Throughout this paper we
hope to illustrate that, rather than anchoring estimates to particular hard-coded values, priors can induce intricate correlation
structures between parameters. These correlation structures stabilize causal effect estimates when data are sparse (as it often is in
scientific applications). This is often referred to as “shrinkage”. Priors can also be used to induce “sparsity” on whole parameter
vectors. Specifically, for high-dimensional vectors, we can place priors that express the belief that some portion of the vectors
are nearly zero. Priors can also be used to conduct probabilistic sensitivity analyses around causal identification assumptions.
All of these are pragmatic motivations for taking a Bayesian approach to causal estimation, even if one is not a Bayesian “at
heart”. We will emphasize that, perhaps contrary to intuition, common frequentist approaches can often be seen as special cases
of these Bayesian estimators with very rigid priors.
3 PARAMETRIC MODELS IN POINT-TREATMENT SETTINGS
In the following sections, we outline two examples where a Bayesian approach to causal inference offers unique benefits in the
form of prior shrinkage. Although these examples use relatively simple parametric models, they reflect the general approach
and intuition of Bayesian causal inference and help motivate key tools such as the Bayesian bootstrap.
3.1 Causal Dose Effects with AR1 Prior
Consider a setting where treatment consists of 퐾 dose levels 퐴푖 ∈ {0, 1,… , 퐾}, with 퐴푖 = 0 indicating no treatment. Let
퐴푖푘 = I(퐴푖 = 푘) be an indicator that subject 푖was assigned to dose 푘 ∈ {1,… , 퐾}. Here, we assume the dose values are ordered
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so that they are increasing with 푘. That is, dose 푘 + 1 is higher than dose 푘. Consider a linear outcome model,
퐸[푌푖 ∣ 퐴,퐿푖] = 휃0 + 퐿′푖훽 +
퐾∑
푘=1
휃푘퐴푖푘. (3)
Suppose our estimand of interest is a causal incremental dose effect curve on Ψ(푘) = 퐸[푌 퐴=푘] − 퐸[푌 퐴=푘−1]. This is a curve
as a function of dose, 푘. Each point on the curve is the causal effect of increasing dose from level 푘 − 1 to level 푘. Under mild
extensions of 퐼퐴.1-퐼퐴.4 from the binary treatment setting to the multi-treatment setting we can again identify this estimand as
Ψ(푘) = 휃푘 − 휃푘−1 푘 ∈ {2,… , 퐾}
Where the first point is Ψ(1) = 휃1. We consider several prior choices for 휃1∶퐾 and the induced prior on Ψ(푘). Throughout,
푢푎∶푏 for intergers 푎 < 푏 denotes the vector 푢 = (푢푎,… , 푢푏). A first-pass approach may be to express prior independence and
factorize the joint prior as 푝(휃1∶퐾 ) =∏퐾푘=1 푝(휃푘). We could specify each term to be Gaussian centered at some prior mean, 휇푘,and standard deviation, 휏푘. However, we can formulate more useful priors in this setting. The increasing dose levels may give
us prior reason to believe that the effect of neighboring doses are actually correlated, not fully independent. This motivates an
alternative (dependent) prior factorization: 푝(휃1∶퐾 ) = 푝(휃1)푝(휃2 ∣ 휃1)∏퐾푘=3 푝(휃푘 ∣ 휃퐾−1, 휃퐾−2). Each term is specified as
휃1 ∼푁(휇1, 휏1)
휃2 ∣ 휃1 ∼푁(2휃1, 휏2)
휃푘 ∣ 휃푘−1, 휃푘−2 ∼푁(2휃푘−1 − 휃푘−2, 휏푘), 푘 > 2,
where 휇1, 휏1∶퐾 are all hyperparameters that we can specify. Alternatively, we could specify hyperpriors for these parameters.
The above induces the following first-order autoregressive (AR1) prior on the causal curve, Ψ(푘). For instance, the last line for
푘 > 2 above implies that 휃푘 − 휃푘−1 ∣ 휃푘−1, 휃푘−2 ∼ 푁(휃푘−1 − 휃푘−2, 휏푘). This follows from simply subtracting 휃푘−1 from 휃푘 and its
mean. Using the definition of Ψ(푘), we see that this statement is equivalent to Ψ(푘) ∣ 휃푘−1, 휃푘−2 ∼ 푁(Ψ(푘 − 1), 휏푘). Extending
this logic, the hierarchical prior on 휃s induces the following prior on the Ψs
Ψ(1) ∼ 푁(휇1, 휏1)
Ψ(푘) ∣ Ψ(푘 − 1) ∼ 푁(Ψ(푘 − 1), 휏푘), 푘 > 1
(4)
This expresses the prior belief that the response from increasing dose to the next level should not be too different from the
response due to the previous dose level. That is, neighboring points on the curve are related. Of course, if we have data suggesting
otherwise, the data will drive our posterior inference away from this prior. However, in the absence of data, this provides valuable
shrinkage back towards a sensible prior belief. An example using synthetic data is presented in Figure 1a with posterior sampling
done in Stan13. Implementation details along with a more thorough walkthrough using this synthetic data set are available in
Appendix A. Implementation via PROC MCMC in SAS is also discussed. Notice in the figure that small sample sizes at each
dose level lead to erratic MLE estimates. In contrast, the Bayesian estimate with the AR1 prior produces a smoother curve. In
dose level 8, we only have three observations. Thus, the Bayes estimate is aggresively shrunk towards the estimate at dose 7.
A common heuristic solution to this issue of decreasing sample size with increasing dose is to fully pool patients at, say,
dose 퐾 and 퐾 − 1 and estimate a single effect for both rather than allowing separate effects. The prior in (4) is a compromise
between these two extremes. Recall from (4) thatΨ(퐾) ∣ Ψ(퐾 −1) ∼ 푁(Ψ(퐾 −1), 휏퐾 ) for퐾 > 1. Now notice that the heuristic
alternative of combining groups 퐾 and 퐾 − 1 corresponds to the strong prior belief that 휏퐾 ≈ 0. That is, the causal effect at
dose 퐾 is a point-mass distribution at Ψ(퐾 − 1): Ψ(퐾) ∣ Ψ(퐾 − 1) ∼ 훿Ψ(퐾−1).
3.2 Partial Pooling of Conditional Causal Effects
Here we consider a more involved model for causal estimation using a logistic regression with binary outcome and treatment.
Here, the mean function 퐸[푌 ∣ 퐴,퐿] is related to the covariates 퐿 through a (non-linear) logit link with inverse logit denoted
by 휎{⋅}. Thus, the integration over 퐿 in (1) must be evaluated explicitly. Consider some 푞−dimensional subset of pre-treatment
covariates, 푉 ⊂ 퐿. Let푊 = 퐿 ⧵ 푉 be the set difference so that 퐿 = {푊 ,푉 }. One target estimand of interest in this setting is
a causal odds ratio at each level of 푉
Ψ(푣) =
퐸[푌 1 ∣ 푉 = 푣]∕(1 − 퐸[푌 1 ∣ 푉 = 푣])
퐸[푌 0 ∣ 푉 = 푣]∕(1 − 퐸[푌 0 ∣ 푉 = 푣])
(5)
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Causally, this is contrasting the odds of the outcome had everyone in stratum 푉 = 푣 taken treatment 1 versus treatment 0.
Since we allow for different treatment effects for each level of 푣, sometimes the set of Ψ(푣) is referred to as a heterogenous
treatment effects or conditional treatment effects (i.e. conditional on 푉 = 푣). Under extensions of 퐼퐴.1−퐼퐴.4, each conditional
expectation in Ψ(푣) is identified as 퐸[푌 푎 ∣ 푉 = 푣] = ∫ 퐸[푌 ∣ 푎, 푉 = 푣,푊 ]푑푃푣(푊 ). Where 푃푣(푊 ) = 푃 (푊 ∣ 푉 = 푣) is theconfounder distribution within stratum 푣. Note that this is just (1) conditional on 푉 = 푣. The regression model is
퐸[푌 ∣ 퐴 = 푎, 푉 ,푊 ] = 휎
{
훽′푤푊 + 훽
′
푣푉 + (휃0 + 휃
′
1∶푞푉 )퐴
} (6)
Above, we include an intercept in푊 . Note that the treatment effect, 휃0+휃′1∶푞푉 , varies with levels of 푉 . We defer discussion ofthe integration over푊 to Section 3.3. For concreteness, suppose 푉 is a vector of indicators for 푞 = 4 race/ethnicity categories:
Black, Asian, Hispanic, Native American, and White as reference. Often some categories (e.g. Hispanic, Asian, Native Amer-
ican) are sparse. In these settings, it is common to combine these categories into “Other” and estimate a single odds ratio for
these subjects. It is also common to simply exclude these subjects and not compute causal effects for these strata at all. Neither
of these may be desirable and, again, carefully formulated priors can help us strike a balance when estimating conditional causal
effects. For instance, consider the prior assumption that all of these conditional (we have not marginalized over푊 yet) effects
within race category (휃0, 휃0 + 휃1, . . . , 휃0 + 휃4) are normally distributed around some “overal” treatment effect 휇 with standard
deviation 휏. We can achieve this by specifying a Gaussian prior for the conditional effect in the reference stratum 휃0 ∼ 푁(휇, 휏).
For the conditional effect in stratum 푉 = 1, we specify 휃0 + 휃1 ∼ 푁(휇, 휏). This is the same as saying 휃1 ∼ 푁(휇 − 휃0, 휏).
Following this logic for the other strata, the joint prior over all parameters is
푝(휃0∶4 ∣ 휇, 휏) = 푁(휃0 ∣ 휇, 휏)
4∏
푗=1
푁(휃푗 ∣ 휇 − 휃0, 휏) (7)
For categories with many observations, the posterior of the conditional effects with race category will be driven mostly by data.
However, for small categories, each conditional effect shrinks to the overall average across race values, 휇. The hyperparameter
휏 controls how aggressively we shrink these conditional effects to the overall average. This allows us to estimate regularized
race-specific causal effects rather than abandoning the task altogether or resorting to ad-hoc groupings of categories. Priors for
휇, 휏, and the other regression coefficients must be specified. Standard guidance14 can be followed when specifying priors on
these nuisance parameters. Similar to the dose effect example, the heuristic approach of fully pooling sparsely populated race
clusters corresponds to a rigid prior. In this case, a prior belief that the conditional effect in all the pooled strata are the same.
3.3 Standardization via Bayesian Bootstrap
To compute conditional causal effects in (5), we must integrate the logistic regression in the previous example over 푃푣(푊 ).
As shown earlier, factors involving 푊 would cancel out in a linear model - obviating the need for explicit integration. Here,
due to the non-collapsability of the logit link, 푊 does not cancel. To compute this integral, we need an estimate of 푃푣(푊 )
over which to integrate. Let 푆푣 = {푖 ∶ 푉푖 = 푣} be the set of indices of subjects in stratum 푉 = 푣. There are 푛푣 subjects in
stratum 푣, so that the size of 푆푣 is 푛푣. A frequentist nonparametric approach would be to estimate the distribution empirically as
푃̂푣(푤) =
1
푛푣
∑
푗∈푆푣 훿푊푗 (푤), where 훿푊푗 (⋅) is the degenerate distribution at푊푗 . This places probability mass 1∕푛푣 on each of the
푛푣 subjects in stratum 푣. This yields average potential outcome estimate
퐸[푌 푎 ∣ 푉 = 푣] ≈ 1
푛푣
∑
푗∈푆푣
퐸[푌 ∣ 퐴 = 푎, 푉 = 푣,푊 = 푊푗]
in stratum 푣. This is ideal in the sense that we impose no parametric model on the conditional distribution of푊 , but is unsatis-
factory from a Bayesian point of view because it ignores the uncertainty in the empirical estimate. This motivates the Bayesian
bootstrap (BB)15. The BB begins with a model for푊 , 푃푣(푤) = ∑푗∈푆푣 푝푣푗 ⋅훿푊푗 (푤). We store all the weights in this stratum in an
푛푣−dimensional vector 푝푣 = {푝푣푗 ∶ 푗 ∈ 푆푣}. This weight vector 푝푣 live in a simplex 푝푣 ∈ {ℝ푛푣 ∶ 푝푣푗 > 0 ∀푗 and ∑푗∈푆푣 푝푣푗 = 1}.Rather than fixing 푝푣푗 = 1∕푛푣, the BB treats the weights as unknown with a flat Dirichlet prior 푝푣 ∼ 퐷푖푟(0푛푣), where 0푛푣 isthe 푛푣−dimensional vector of zeros. This yields the (conjugate) posterior 푝푣 ∣ 푊 ∼ 퐷푖푟(1푛푣), where 1푛푣 is the 푛푣−dimensionalvector of ones. The BB makes minimal assumptions about the confounder distribution within each stratum: note the posterior
mean of each weight is also 1∕푛푣 (same as the frequentist approach), but allows uncertainty around this mean to flow through
to the causal effect in that stratum.
The BB was applied to marginal ATE estimation using generalized linear models (GLMs) for the outcome by Wang et al.16.
When computing a marginal ATE, the BB is used as a model for the marginal 푝(퐿) not the conditional 푝푣(푊 ). In the outcome
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model, we no longer set 푉 = 푣 since 푉 is included in퐿 = {푊 ,푉 }, which we integrate over. The BBmodel is now 푃 (푙 ∣ 푝1∶푛) =∑푛
푖=1 푝푖훿퐿푖(푙). Now we place a Dirichlet prior on the 푛-dimensional vector 푝1∶푛 rather than the 푛푣-dimensional vectors 푝푣. Thismarginal estimate will play a key role in the nonparametric estimation of Section 6.
Full posterior inference for the causal odds ratio (5) requires just a few additional steps after sampling. Suppose we obtain the
푚푡ℎ draw of the parameters in (6), {훽(푚)푤 , 훽(푚)푣 , 휃(푚), 휃(푚)1∶푞}. Then, for each stratum 푣, we draw BB weights 푝(푚)푣 ∣ 푊 ∼ 퐷푖푟(1푛푣).
Note that here 푝(푚)푣 denotes the collection {푝(푚)푣푗 ∶ 푗 ∈ 푆푣}. Then, we do the following
1. Integrate under both interventions 퐴 ∈ {1, 0}:
휇(푚)(푎, 푣) =
∑
푗∈푆푣
푝(푚)푣푗 휎
{
훽 ′(푚)푤 푊푗 + 훽
′(푚)
푣 푣 + (휃
(푚) + 휃
′(푚)
1∶푞 푣)푎
}
2. Compute Causal Effects for each 푣
Ψ(푚)(푣) =
휇(푚)(1, 푣)∕(1 − 휇(푚)(1, 푣))
휇(푚)(0, 푣)∕(1 − 휇(푚)(0, 푣))
Doing this for 푚 = 1,… ,푀 posterior parameter draws yields 푀 draws from the posterior of the causal estimand:
{Ψ(푚)(푣)}1∶푀 for each 푣. These draws can be used for posterior inference. Figure 1b shows posterior estimates of Ψ(푣) with the
partial pooling prior in (7) using synthetic data. MCMC-based posterior inference was done using Stan. Notice that for strata
푉 ∈ {4, 5}, we have relatively few observations. In these strata, the maximum likelihood estimate (MLE) is much higher than
the others due to small sample variability. Thus, the Bayesian prior aggressively shrinks the posterior mean estimate away from
MLE towards the overall effect. From a causal perspective, we can view this as shrinking the heterogenous treatment effects
towards an overall treatment effect. Details of this synthetic data generation and implementation in both Stan and SAS are given
in Appendix B. The latter relies on PROC MCMC for posterior sampling and PROC IML for the BB post-processing step.
4 TIME-VARYING TREATMENT AND CONFOUNDING
The previous sections focused on the point-treatment setting: estimating the causal effect of a single treatment administered
at baseline while adjusting for a single set of pre-treatment parameters. In many applications, treatment decisions are made
sequentially over time as a function of covariates measured after baseline. For example, consider a binary treatment setting where
treatment at time 푡 = 0, 퐴0, is assigned conditional on confounders, 퐿0, measured before 퐴0. The subsequent treatment, 퐴1,
is assigned conditional on 퐿0, 퐴0, and 퐿1, where 퐿1 is measured between 퐴0 and 퐴1, temporally. After treatment, we observe
a single outcome 푌 . Suppose we wish to estimate the causal ATE 퐸[푌 (1,1) − 푌 (0,0)] - the difference had everyone in the target
population been always treated versus never treated. Note the potential outcomes here are indexed by a treatment vector, not
scalar. In the literature this vector is often referred to as a “treatment regime” or “treatment policy”. In this section, we first
discuss causal contrasts comparing outcomes that would have been realized under two different static treatment regimes while
controlling for time-varying confounding. Static regimes are treatment vectors that are pre-set to fixed values in advance (e.g.
always treated, never treated, alternating treatments). Afterwards, we discuss an extension to dynamic treatment regimes, where
the treatment regime is set sequentially over time according to a pre-specified rule (e.g. treat at time point 푡 if blood pressure at
time 푡 is lower than some threshold). We refer the reader to Daniel8 for a thorough tutorial on time-dependent confounding and
modeling.
4.1 Comparing Static Treatment Regimes
Standard regressionmethods fail to properly adjust for the time-varying confounder in these settings. For instance, if we condition
on퐿1, then we adjust away퐴0’s impact on 푌 that runs through퐿1. However,퐿1 is a confounder of퐴1 and 푌 - so failing to adjust
for it will also lead to bias. Now, generalizing to 푡 = 0,… , 푇 time points, under extensions of 퐼퐴.1 − 퐼퐴.4 to this sequential
setting2 we can identify each term of the causal contrast Ψ = 퐸[푌 푎0∶푇 − 푌 푎′0∶푇 ] as
퐸[푌 푎0∶푇 ] = ∫
퐸[푌 ∣ 푎0∶푇 , 퐿0∶푇 ] ×
푇∏
푡=0
푝(퐿푡 ∣ 퐿0∶푡−1, 푎0∶푡−1)푑퐿0∶푇 (8)
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(a) (b)
FIGURE 2 A directed acyclic graph (DAG) showing a time-varying treatment, 퐴푡, time-varying confounder 퐿푡, and outcome,
푌 , for three time points. In the first panel, treatment and confounding at each time point affects treatment and confounding in
every future time point. The second panel depicts the Markov assumption described in Section 4.1 - confounders and treatment
only impact variables in the next period so that 푝(퐿2 ∣ 퐿0∶1, 퐴0∶1) = 푝(퐿2 ∣ 퐿1, 퐴1). This is visually depicted by the deletion of
the gray arrows in the first panel. Bayesian methods can help us strike a balance between these two extremes.
Where for 푡 = 0, we define 푝(퐿0 ∣ 퐿0∶−1, 푎0∶−1) = 푝(퐿0). The expression above is known as the 푔-formula and the computation
of the integral is referred to as 푔-computation - it is the multi-time point generalization of standardization in (1). Here we ignore
the details of identification to focus on Bayesian modeling and computation.
In particular, note that the above requires integrating an outcome regression over the joint distribution of confounders, con-
ditional on treatment regime 푎0∶푇 . The outcome regression here can be high-dimensional even in common data applications.
If we have just two time-varying confounders and twelve (e.g. monthly) time points, the outcome model must condition on 36
variables. Similarly, each conditional confounder distribution must (usually) be modeled conditional on all previous values of
퐿푡 and 퐴푡 - another high-dimensional modeling task.
The sequential nature of treatment and confounder measurement can be visually depicted using a directed acyclic graph
(DAG) in Figure 2a for 푇 = 3 timepoints (for compactness). Notice 퐿2 is impacted by all previous confounder values (퐿0 and
퐿1) and treatment values (퐴0 and 퐴1). This is shown by arrows going into 퐿2. Similarly, the outcome is impacted by all past 퐿
and 퐴 values. To simplify this complexity, a Markovian assumption is commonly invoked. This assumes that each confounder
distribution only depends on the previous confounder and treatment values, 푝(퐿푡 ∣ 퐿0∶푡−1, 퐴0∶푡−1) = 푝(퐿푡 ∣ 퐿푡−1, 퐴푡−1). A similar
assumption may be used in the outcome model. This Markov-type assumption is depicted in Figure 2b, which is simply the DAG
in 2a with all the gray arrows removed. After removing gray arrows, each variable is directly impacted only by variables in the
preceding time point. In Figure 2b, for instance, once we know 퐿1 and 퐴1, we know the distribution of 퐿2. The history (퐴0 and
퐿0) need not be considered since it only affects 퐿2 through 퐿1 and 퐴1. Thus, 푝(퐿2 ∣ 퐿0∶1, 퐴0∶1) = 푝(퐿2 ∣ 퐿1, 퐴1).
Neither of these extremes - conditioning on full history or invoking Markov - are completely desirable. Suppose 퐿푡 is an
indicator of poor kidney function at day 푡. The Markov assumption presumes that two treated subjects with, say, poor kidney
function on the previous day, 퐿푡−1, have the same 퐿푡 distribution - even if one patient had poor function everyday since 푡 = 0
and the other had good function until day 푡 − 1. This seems unrealistic. On the other hand, it may also be unrealistic to say that
kidney function on day 1, 퐿1, would directly impact function on, say, day 100, 퐿100. In the Bayesian paradigm, we can devise
priors that balance these two extremes of either conditioning only on previous time period’s values versus conditioning on the
entire past history. The general idea is to condition on the full history, but express a prior belief that values closer in time to the
present have relatively more direct impact on the present. Conversely, values further back in time have small, if any, direct effect.
To continue this example, consider a simple setting where 퐿푡 is a continuous measure of kidney function and the outcome
is viral load, with the treatment, 퐴푡 ∈ {0, 1} being anti-viral therapy at time 푡. Lower viral load is desirable, but comes at the
expense of nephrotoxicity. So, depending on previous treatment, if the patient shows poor kidney function as measured by 퐿,
the physician may alter their treatment. To evaluate (8), we will need an outcome regression and a sequence of conditional
confounder models. Consider a linear outcome regression 퐸[푌 ∣ 퐴0∶푇 , 퐿0 ∶ 푇 ] = 훾 + 퐿′0∶푇 훽푌 + 퐴′0∶푇 휃푌 and a Gaussian
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(a) Plot of coefficient estimates from (9) with t=9. Each coef-
ficient on the x-axis is the effect of 퐿푡 on 퐿9 for time points
푡 = 0,… , 8. Note aggressive shrinkage of 훽0 but ability to
detect signal in the past at 훽1.
(b) Sensitivity analysis of Section 5. Posterior Distribution of
Ψ푠 = Ψ − Δ under various priors for for Δ. Red line indicates
true value.
FIGURE 3 Example of 푔-computation on synthetic data with 10 time points, single time-varying treatment and confounder.
The ridge prior in (10) was used along with Gaussian outcome and conditional confounder models.
conditional model for 퐿푡 with conditional mean
휇퐿푡(퐿0∶푡−1, 퐴0∶푡−1) = 훽 + 퐿
′
0∶푡−1훽퐿 + 퐴
′
0∶푡−1휃, (9)
where 훽퐿 = (훽0, 훽1, 훽2,… , 훽푡−1) and 휃 are length 푡 parameter vectors. We note that these parameters should be indexed by 푡 (e.g.
훽푡퐿) as each conditional distribution should be allowed to have their own effects, but we omit this indexing for compactness. Weconsider the following prior on each element of 훽퐿
훽푡−푘 ∼ 푁(0, 휏푘휙), 푘 ∈ {1,… , 푡}. (10)
An identical prior can be used for 휃. Consider the specification 휏푘 = (1∕휆푘) for some 휆 > 1. This corresponds to what is often
referred to as a ridge penalty in the machine learning literature. However, it differs from the standard ridge regression in that we
do not apply the same penalty to all coefficients. Rather, the penalty gets increasingly aggressive for coefficients going farther
back in time. For instance, for 휆 = 2, the prior standard deviation around 0 is halved every step backward in time, providing
increasingly aggressive prior shrinkage towards 0. This implies a strong prior belief that recent confounder values are more
likely to influence the present than values farther in the past. Note that the Markov assumption follows from a special (strongly
informative) case of this prior, where 훽푡−푘 ∼ 훿0 for 푘 > 1: all coefficients but 훽푡−1 follow a point-mass distribution at 0. An
example of the prior in (10) is provided in Figure 3a with 푇 = 9. The plot shows the coefficients of 훽퐿 in the model 휇퐿9 gettingincreasingly penalized. Note that the posterior estimate of 훽1 is able to break away from this prior to detect a signal (a truly non-
zero coefficient value), even though it is farther in the past. However, at time point 0 the posterior estimate 훽0 is strongly shrunk
to zero (relative to the MLE).
The Bayesian literature has explored several such “sparsity” priors, including the horseshoe17, LASSO, and spike-and-slab
priors18 - all of which could be applied to 푔-computation. These priors can all be characterized by their ability to both shrink
noise, while being able to break away from the prior to detect signals17. For instance, a horseshoe type prior on the components
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of 훽퐿 can be specified by placing half-Cauchy hyper-priors on 휏푘 and 휙 in (10):
휏푘 ∼퐶+(0, 1∕2푘)
휙 ∼퐶+(0, 휈)
where 휈 is a specified scale parameter that controls overall shrinkage across time. Similar to the ridge-type prior, the scale on
the distribution of 휏푘 is halved every step backward in time.
The integration in (8) can be done via Monte Carlo after obtaining MCMC draws from the posterior of all the parameters
governing the conditional confounder and outcome distributions. Conditional on these draws, we can simulate confounder values
from these distributions and take the average of our regression model over these simulated values. Let 휔(푚)푦 denote the 푚푡ℎdraw of the parameter vector governing the regression in (8). Similarly, denote the parameter vector governing each conditional
confounder distribution 푝(퐿푡 ∣ 퐿0∶푡−1, 푎0∶푡−1) by 휔(푚)퐿푡 . For instance, these would include draws of the regression parameters
훽, 훽퐿, 휃 in (9) along with the Gaussian variance parameter. In the viral load example discussed earlier, 휔(푚)푦 would consist of
휔(푚)푦 = (훾
(푚), 훽(푚)푌 , 휃
(푚)
푌 )
To compute the causal ATE Ψ = 퐸[푌 푎0∶푇 − 푌 푎′0∶푇 ] of regime 푎0∶푇 versus 푎′0∶푇 , with each posterior draw of 휔(푚)푌 and 휔(푚)퐿푡 we:
1. Draw confounders, for 푡 ∈ 0… 푇 sequentially
퐿̃푡 ∼ 푝(퐿푡 ∣ 퐿̃0∶푡−1, 푎0∶푡−1, 휔
(푚)
퐿푡
)
Denote these draws 퐿̃0∶푇 = (퐿̃0, 퐿̃1… , 퐿̃푇 ). Repeat this a total of 퐵 times to obtain {퐿̃(푏)0∶푇 }1∶퐵 = {퐿̃(1)0∶푇 , 퐿̃(2)0∶푇 ,… 퐿̃(퐵)0∶푇 }
2. Integrate the outcome model 퐸[푌 ∣ 푎0∶푇 , 퐿0∶푇 ] over {퐿̃(푏)0∶푇 }1∶퐵 conditional on current set of draws 휔(푚)푦 , under bothinterventions. In the viral load example, this would be
휇(푚)(푎0∶푇 ) =
1
퐵
퐵∑
푏=1
퐸[푌 ∣ 푎0∶푇 , 퐿̃
(푏)
0∶푇 , 휔
(푚)
푦 ]
= 1
퐵
퐵∑
푏=1
(훾 (푚) + 퐿̃
′(푏)
0∶푇 훽
(푚)
푌 + (푎0∶푇 )
′휃(푚)푌 )
Similarly, repeat Step 1 and 2 under 푎′0∶푇 .
3. Compute Causal Contrast
Ψ(푚) = 휇(푚)(푎0∶푇 ) − 휇(푚)(푎′0∶푇 )
This procedure yields푀 posterior draws of Ψ, which can be used to form posterior mean and credible intervals. This can also
be implemented in Stan using the “generated quantities” block as demonstrated in the our code on GitHub. The number of
draws 퐵 should be large so that the Monte Carlo error of the integration of (8) is sufficiently low. In general, analyses with more
time points and time-varying confounders will require larger 퐵. In practice, we can try running steps 1-3 for a single posterior
draw (say, draw 푚), over successively larger 퐵. Keeping track of each repetition, we can check at which point increasing 퐵
only marginally increases precision in the estimate of Ψ(푚). We can then set 퐵 to this value across all posterior draws. A nice
feature of this Bayesian approach is that uncertainty about the confounder and outcome models at all time points naturally flows
through to the posterior of Ψ or any other causal contrast. For instance, we could have computed posterior draws of causal ratio
contrast퐸[푌 푎0∶푇 ]∕퐸[푌 푎′0∶푇 ] in Step 3 as 휇(푚)(푎0∶푇 )∕휇(푚)(푎′0∶푇 ). In contrast, the frequentist approachwould requiremany bootstrapestimates of the parameter vectors. Then, we would repeat Steps 1-3 using these bootstrap draws in place of the posterior draws.
In the Bayesian framework, we need not re-estimate the model. We simply post-process the same set of draws differently.
4.2 Dynamic Treatment Regimes
In the previous section we compared static treatment vectors 푎0∶푇 = (푎0, 푎1,… , 푎푇 ), where each element is fixed at baseline.
A dynamic treatment regime is a treatment regime where the elements are determined dynamically post-baseline via a pre-
specified decision rule. A decision rule is a function that, at each time point 푡, maps the confounder history and treatment history
(퐿0∶푇 , 퐴0∶푇 ) to a treatment value 푎푡 ∈ {0, 1}. For simplicity, here we discuss treatment rules that determine assignment based
on current confounder values only. That is, rules 푟푡(⋅) ∶ → {0, 1}maps from the space of confounders to a treatment decision.
Expanding on the viral load/kidney function example from earlier, consider a treatment rule that administers treatment at time 푡
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only if kidney function at time 푡 is higher than some threshold 휅: 푟푡(퐿푡) = 푟(퐿푡) = 퐼(퐿푡 > 휅). We denote the average potential
outcome under the dynamic treatment regime 푎푟0∶푇 = (푟(퐿1), 푟(퐿2),… , 푟(퐿푇 )) as 퐸[푌 푎
푟
0∶푇 ]. Of interest may be to compare the
average difference in outcome had everyone been treated according to rule 푟 versus rule 푑: Ψ = 퐸[푌 푎푟0∶푇 − 푌 푎푑0∶푇 ]
We note that these rules can be quite complex. For example, treatment at time 푡 may only be assigned if kidney function has
been above 휅 for the previous two periods as well as the current time period:
푟푡(퐿(푡−2)∶푡) = 퐼(퐿푡 > 휅푡) ⋅ 퐼(퐿푡−1 > 휅푡−1) ⋅ 퐼(퐿푡−2 > 휅푡−2)
Here, 푟푡(⋅) ∶ 3 → {0, 1}. In general, the rule may include previous treatment history as well as confounder history. In this
section we consider the simple rule 푟(퐿푡) = 퐼(퐿푡 > 휅), but the procedure is the same for more complicated rules.
As shown in all previous examples, Bayesian causal inference can be done quite easily provided we have posterior draws of
the model parameters. Once these are obtained, computing causal contrasts is just a matter of post-processing. In this case, we
only need to modify the 푔-computation post-processing steps from the previous section to sequentially set each element of the
treatment vector as confounders are simulated, rather than use a pre-set treatment vector 푎0∶푇 .
Consider the same scenario as in the static treatment setting, with posterior draw of휔(푚)푌 and휔(푚)퐿푡 , but this time with a specifieddynamic treatment rule 푟(퐿푡) = 퐼(퐿푡 > 휅). We compute a draw, 휇(푚)(푟), from the posterior of the average potential outcome
under rule 푟, 퐸[푌 푎푟0∶푇 ], as follows
1. Starting from 푡 = 1, perform the following two sub-steps sequentially until 푡 = 푇
(a) Simulate Confounder
퐿̃푡 ∼ 푝(퐿푡 ∣ 퐿̃0∶푡−1, 푎̃0∶푡−1, 휔
(푚)
퐿푡
)
(b) Determine Treatment according to rule
푎̃푡 = 푟(퐿̃푡) = 퐼(퐿̃푡 > 휅)
Denote these draws 퐿̃0∶푇 = (퐿̃0, 퐿̃1… , 퐿̃푇 ) and 퐴̃0∶푇 = (푎̃0, 푎̃1,… , 푎̃푇 ). Repeat this a total of퐵 times to obtain {퐿̃(푏)0∶푇 }1∶퐵and {퐴̃(푏)0∶푇 }1∶퐵
2. Integrate the outcome model 휇(푚)(푟) = 퐸[푌 ∣ 푎푟0∶푇 , 퐿0∶푇 ] over {퐿̃(푏)0∶푇 }0∶푇 and {퐴̃(푏)0∶푇 }1∶퐵 conditional on current set ofdraws 휔(푚)푦 , under both interventions. In the viral load example, this would be
휇(푚)(푟) = 1
퐵
퐵∑
푏=1
퐸[푌 ∣ 퐴̃(푏)0∶푇 , 퐿̃
(푏)
0∶푇 , 휔
(푚)
푦 ]
Similarly, we can draw from the posterior of average potential outcome under an alternative rule 푑, 퐸[푌 푎푑0∶푇 ]. Denote this by
휇(푚)(푑). Taking the difference yields a posterior draw of Ψ, Ψ(푚) = 휇(푚)(푟) − 휇(푚)(푑). The sum over 퐵 is a Monte Carlo estimate
of the integral in (8). This highlights the advantage of full posterior inference. A posterior over the model parameters induces a
posterior over functions of those parameters - in this case, ATEs that contrast dynamic treatment regimes.
5 PRIORS OVER SENSITIVITY PARAMETERS
So far we have demonstrated how priors can be used to induce various correlation structures between model parameters. In
Section 3.1, we were able to estimate a smoothed causal curve by inducing correlation between neighboring points. In section
3.2, we were able to estimate conditional causal contrasts for sparsely populated subgroups by shrinking their estimates towards
the overall average. Lastly, in the previous section we explored ridge-like and horseshoe priors for inducing principled sparsity
on a high-dimensional covariate vector. In this section, we present a different use of priors focused explicitly on causality rather
than modeling - outlining how they can be used to express uncertainty about causal identification assumptions.
We consider a binary point-treatment setting with a continuous real-valued outcome. Suppose that conditional ignorability
(퐼퐴.1) does not hold, so that 푌 푎 ̸⟂ 퐴 ∣ 퐿, for 푎 ∈ {0, 1}. This implies that 퐸[푌 푎 ∣ 퐴 = 1, 퐿] ≠ [푌 푎 ∣ 퐴 = 0, 퐿]. That is,
the mean of each potential outcome differs between those actually treated and untreated, even after conditioning on 퐿. Suppose
they differ by
Δ푎(퐿) = 퐸[푌 푎 ∣ 퐴 = 1, 퐿] − 퐸[푌 푎 ∣ 퐴 = 0, 퐿]
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This could be a result of selection bias. For instance, if higher outcome values are beneficial then 퐸[푌 0 ∣ 퐴 = 1, 퐿] < 퐸[푌 0 ∣
퐴 = 0, 퐿] implies those assigned to treatment would have had worse outcomes even if they had not been treated, relative to those
not assigned treatment. This could be caused by “confounding by indication” where patients worse-off to begin with are more
likely to be treated with more advanced drugs. Not accounting for this selection bias may make these drugs look ineffective and,
perhaps, even harmful.
In this setting, if we were to incorrectly assume 퐼퐴.1, then standardization in (1) would yield a biased estimated of the causal
effect Ψ = 퐸[푌 1 − 푌 0]:
∫
{휇(1, 퐿) − 휇(0, 퐿)}푑푃 (퐿) = Ψ + 휉
where the bias term, 휉, is a function of Δ푎(퐿) and the propensity score 푒(퐿) = 푃 (퐴 = 1 ∣ 퐿)
휉 = ∫
{Δ0(퐿)푒(퐿) + Δ1(퐿)[1 − 푒(퐿)]}푑푃 (퐿). (11)
Above, 휉 fully characterizes the implication of an ignorability violation on our estimate, but has a complicated form: it is a func-
tion of the treatment probability and two unknown functions, Δ1(퐿) and Δ0(퐿). Since ignorability is an untestable assumption,
it is inherently impossible to learn about Δ1(퐿) and Δ0(퐿) through the observed data. To proceed, we must make assumptions
about the form of the ignorability violation. The art of sensitivity analysis lies in making assumptions that balance the trade-
off between the range of violations that can be explored against the interpretability of the sensitivity parameters. If they are
not interpretable, we cannot form sensible prior beliefs about them. But if they are too simple, we will fail to explore realistic
violations.
As an example, suppose that Δ1(퐿) = Δ0(퐿) = Δ so that both potential outcomes differ by some constant amount between
those assigned and unassigned treatments. That is, there is some constant boost that one treatment group is getting under both
hypothetical treatment interventions. We also assume this bias is constant with respect to measured covariates, so that we learn
nothing about the bias by conditioning on 퐿 (a worse-case scenario). In this setting, the bias reduces to 휉 = Δ ∫ 푑푃 (퐿) = Δ.These assumptions reduce (11) to be a function of a single parameter which, as mentioned earlier, can be viewed as the amount
of selection bias: Δ = 퐸[푌 0 ∣ 퐴 = 1, 퐿] − 퐸[푌 0 ∣ 퐴 = 0, 퐿]. If higher 푌 values are beneficial, then Δ < 0 implies treated
subjects would have had outcome values Δ units lower than those not assigned treatment, even had they not been treated. This
could be because of a lurking unmeasured confounder (e.g. baseline disease severity) that impacts both treatment assignment
and outcome. Interpretation of magnitude will depend on the units of 푌 . If 푌 were standardized, we could interpret Δ as a
standard deviation difference in average potential outcomes between the two treatment groups. Suppose we believe that there is
strong possibility of a selection bias in the Δ < 0 direction and no chance of bias in the other direction, we can set Δ = −Δ∗.
We could then specify a prior Δ∗ ∼ 퐺푎푚(푎, 푏), which has prior mean 퐸[Δ∗] = 푎∕푏 and variance 푉 푎푟[Δ∗] = 푎∕푏2. For instance,
if we have a prior belief of a one standard deviation bias, we can set (푎∕푏) = 1 and set 푏 to, say, 푏 = 3. This is a fairly tight prior
around Δ∗ = 1 with standard deviation 3−1∕2.
To illustrate, we generate some synthetic data with a single binary treatment, single continuous observed confounder, a single
continuous unobserved confounder, and a Gaussian outcome with mean being a function of treatment and both confounders.
We then fit the Bayesian linear regression in Equation (2), excluding the unmeasured confounder. Appendix C describes this
synthetic data generation and implementation in more detail. If we had included it, standardization would yield an accurate
estimate of the ATE, Ψ = 퐸[푌 1 − 푌 0], which equals Ψ = 1 in this simulation. However, because we mistakenly exclude the
unmeasured confounder, our estimate will be biased by some Δ. Conducting a sensitive analysis involves specifying different
priors for Δ. Because we have no data about Δ, the posterior is the same as the prior and so the usual standardization algorithm
can be modified as follows:
1. Perform standardization as usual to obtain Ψ(푚). Because we are using a linear model in this simulated example, Ψ(푚)
is simply the 푚푡ℎ posterior draw of the coefficient on the treatment dummy in our regression - as shown in Equation (2).
2. Draw sensitivity parameter from some specified prior, e.g. Δ∗(푚) ∼ 퐺푎푚(1, 3), transform to get Δ(푚) = −Δ∗(푚), and
compute
Ψ(푚)푠 = Ψ
(푚) − Δ(푚).
In this case, our sensitivity analysis produces the usual posterior draws Ψ(푚) that are perturbed by draws of Δ(푚). We can also
view it as “subtracting off” the bias in (11) from the standardization estimate, Ψ(푚). This perturbation incorporates our prior
uncertainty regarding the magnitude of the bias due to a pre-specified form and direction of an ignorability violation. Figure 3b
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presents perturbed posteriors under three different priors for this synthetic example: Δ ∼ 푁(0, 푠푑 = 3−1∕2), Δ ∼ 퐺푎푚(1, 3),
and Δ∗ ∼ 퐺푎푚(1, 3). Note that ignorability (i.e. no unmeasured confounding) can be expressed as a strong prior belief that Δ
follows a point-mass distribution at 0, Δ ∼ 훿0. As shown in Figure 3b, this yields a posterior estimate centered far from Ψ = 1.
The first prior expresses symmetric belief about the direction of the bias, and so increases uncertainty in the posterior, without
shifting its mean. Consequently, in Figure 3b we see the wider posterior interval that now has more mass around Ψ = 1. The
second prior expresses prior belief that Δ > 0 and the third expresses the belief that Δ < 0. Thus, the former shifts our posterior
lower to correct for the upward bias and the latter shifts our posterior up to correct for the downward bias.
While sensitivity analyses around 퐼퐴s are unique and application-specific, they follow the general procedure we outlined
above:
1. Find the bias induced by an 퐼퐴 violation, 휉.
2. Make assumptions about the nature of the violation so that 휉 is expressed in terms of interpretable sensitivity parameters.
3. Express your belief about the direction and degree of the violation via priors on these sensitivity parameters.
4. Use draws from these priors to perturb the causal effect.
5. Assess the perturbed posterior.
We contrast this approach with the usual frequentist approach that computes point and interval estimates for Ψ under a pre-
specified range of Δ. Usually this range is wide enough so that we can see where perturbation “reverses” some statistically
significant effect, as measured by a change in p-value from significant to non-significant. In the Bayesian approach, we see
how perturbation impacts the entire posterior distribution of the estimand - telling us how posterior mean, median, quantiles,
variance, etc are all affected by the uncertainty in our sensitivity parameters.
The literature on Bayesian sensitivity analysis is large and growing. For instance, McCandless et al.19 develop a sensitiv-
ity analysis for unmeasured confounding of the effect of a binary exposure on an outcome and assess the quality of posterior
inference via extensive simulations. Gustafson et al.20 develop a Bayesian sensitivity analysis framework for unmeasured con-
founding where it is assumed measured confounders are measured with error. This highlights a strength of Bayesian approach:
sensitivities aroundmultiple violations (in this case, measurement error and ignorability) can be done at oncewith suitable priors.
Mediation analyses require more complex ignorability assumptions to estimate natural direct and indirect effects. Bayesian sen-
sitivity analyses have been developed for such problems within the context of hazard models for survival outcomes21. Bayesian
sensitivity analysis for mediators have also been explored with nonparametric Bayesian models22. Other work by Gustafson et
al. focus on Bayesian sensitivity for partially identified bias parameters23. They discuss an application to average causal effect
estimation in a randomized trial with non-compliance (i.e. not all patients randomized to treatment 퐴 = 푎 take treatment 푎).
6 FLEXIBLE MODELS VIA NONPARAMETRIC BAYES
In previous examples, we considered parametric regression models 휇(퐴,퐿) = 퐸[푌 ∣ 퐴,퐿] that were indexed by finitely many
parameters. In the Gaussian example of Section 2, the regression was determined completely by (휃, 훽). In Section 3.2, the
logistic regression was a function of (훽푤, 훽푣, 휃0, 휃1∶푞). In our discussion of time-varying confounding, models for the confounder
distribution were required at every time point, in addition to an outcome model. These models impose restrictive functional
forms of the covariate and treatment effect. For instance, they assume that the treatment effects are linear and additive on
some transformation of the conditional outcome mean. However, it is possible that the treatment effect is a complex, nonlinear
function of 퐿. Suppose all relevant confounders sufficient for 퐼퐴.1 to hold are measured and included in the model. Even in this
scenario, msisspecification of the functional form of that model will, in general, yield inaccurate posterior causal effect estimates.
In this section we will provide a brief overview of causal effect estimation using Bayesian nonparametric (BNP) models - a
class of flexible models that make minimal functional form assumptions. We focus here on the point-treatment setting, with
the understanding that these methods can be applied to other settings, including conditional mean modeling in 푔-computation,
mediation, marginal structural models, and so on. Throughout, 퐷 = {푌푖, 퐴푖, 퐿푖}1∶푛 will denote the observed data consisting of
outcome, treatment, and confounder vector for 푛 independent subjects. We will define a covariate vector 푋푖 = (1, 퐴푖, 퐿푖) for
compactness.
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6.1 Dirichlet Process Mixture Models
We return to the linear model of Section 2 and specify a more flexible alternative. First, define conditional regression 휇푖(푋) =
푋′훽푖. We specify the following model for the joint data distribution
푌푖 ∣ 푋푖, 훽푖, 휙푖 ∼ 푁(휇푖(푋푖), 휙푖)
푋푖 ∣ 휃푖 ∼ 푝(푋푖 ∣ 휃푖)
휔푖 ∣ 퐺 ∼ 퐺
퐺 ∣ 훼,퐺0 ∼ 퐷푃 (훼퐺0)
(12)
휔푖 = (휃푖, 훽푖, 휙푖) denotes the full parameter vector. There are two key additions in this model. First, we have saturated the model
with more parameters than there are observations in the data. This is nonparametric in the sense that the number of parameters is
growing with the sample size. Second, this is a generative rather than conditional model. That is, we model the joint distribution
푝(푌푖, 푋푖 ∣ 휔푖) = 푝(푌푖 ∣ 푋푖, 휔푖)푝(푋푖 ∣ 휔푖) rather than just the conditional distribution of the outcome.
The parameters of the joint distribution follow an unknown prior, 퐺. Above, we specify a Dirichlet process (DP) prior on
G. Realizations of this stochastic process are discrete random probability distributions centered around a base distribution,
퐺0(휔푖), with dispersion controlled by 훼. This discreteness induces ties among the 휔푖 which, in turn, induces posterior clustering
of data points. Specifically, subjects are partitioned into groups with similar joint data distributions and each group’s joint is
modeled using a separate 휔푖. In this way, the posterior conditional regression is a mixture of many cluster-specific regressions.
In the machine learning literature24 these are often called “mixture of experts” learners, since each component regression in
the mixture (referred to as an “expert”) has “expertise” in a particular region of the data. Predictions are formed by averaging
over the component experts’ predictions. These are distinct from ensemble models, which model the entire data using separate
candidate models - rather than assigning different data regions to different models.
Induced Posterior Regression
Such DPmixture models have been discussed in the BNP literature for some time. Shahbaba and Neal (2007) first described a DP
mixture of regressions25. Blei et al. (2011) later extended this to aDPmixture of GLMs, which generalizes (12) to any conditional
outcome and covariate distribution in the exponential family26. There is extensive literature on posterior sampling strategies for
this model, though the most common approach in causal inference tends to be Neal’s Algorithm 827. We will use software to
conduct the sampling, but it is instructive to show that the posterior regression can be expressed as a mixture of regressions at
each iteration in the sampler. Let 휔(푚)1∶푛 be a draw of all the subject-level parameters and let 휇(푚)푖 (푋) = 퐸[푌 ∣ 푋,휔(푚)푖 ] denote theposterior regression at each iteration, given by
휇(푚)푖 (푋) = 푤
(푚)
0 휇
(푚)
0 (푋) +
푛∑
푖=1
푤(푚)푖 휇
(푚)
푖 (푋) (13)
Note that this is a mixture with 푛 + 1 components and mixture weights {푤(푚)0 , 푤(푚)1∶푛}. Above, 휇(푚)0 (퐴,퐿) is the regression undera prior draw 훽(푚)0 ∼ 퐺0 - we will call this a “prior regression”. The weights 푤(푚)푖 have the form
푤(푚)푖 =
푝(푋 ∣ 휃(푚)푖 )
훼푝(푋 ∣ 휃(푚)0 ) +
∑푛
푖=1 푝(푋 ∣ 휃
(푚)
푖 )
, (14)
where 휃(푚)0 ∼ 퐺0 is a prior draw. The weight on the prior regression is
푤(푚)0 =
훼푝(푋 ∣ 휃(푚)0 )
훼푝(푋 ∣ 휃(푚)0 ) +
∑푛
푖=1 푝(푋 ∣ 휃
(푚)
푖 )
(15)
The induced posterior regression is a complex mixture of a prior regression and several subject specific regressions. Importantly,
the mixture weights are covariate-dependent, allowing us to capture non-linear and non-additive effects of푋 on the outcome.We
refer to the specified distributions in (12) as “local” distributions as they are local to a particular mixture component. Even though
the local model is parametric, we can approximate arbitrarily complicated distributions using a mixture of locally simple models.
This is similar conceptually to approximating a complicated non-linear regression function using piecewise linear splines.
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(a) BART (b) Dirichlet Process
(c) Gaussian Process (d) ATE Estimates
FIGURE 4 Training and test set predictions from three BNP models, along with ATE estimates from each. Red points indicate
held-out test data. Gray points are training data. Notice for the DP and GP models, the increased uncertainty in the test region.
BART, by contrast, has less uncertainty in this region. Relative to DP and GP, BART’s interpolation is more rigid due to its
inherent tree structure.
Local Model Choice and Hyperparameters
Specification of the model requires specifying the local distributions. In general, model fit will not be too sensitive to these
choices as the resulting regression takes a complex non-linear mixtures of these local models to fit the regression. However,
desired support can be a guiding concern in making this choice. For instance, it may be desirable to choose 푝(푋푖 ∣ 휃푖) such that it
respects the support of the elements of푋푖. Consider a vector푋 = (푋1, 푋2, 푋3) that consists of a binary, continuous/real-valued,
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and count confounders respectively. Assuming prior independence, we can set 푝(푋푖 ∣ 휃푖) to be the product of the Bernoulli,
Gaussian, and Poisson distributions, with 휃푖 being the vector of parameters governing all three distributions. Similarly, if the
outcome must be non-negative (e.g. blood pressure, cost, etc) then we could use a log-normal conditional outcome distribution
instead of a Gaussian.
Just as with the local models, 퐺0 should also be set to place non-zero prior measure on the support of 휔푖. In model (12) with
a single count covariate 퐿푖, we could set
퐺(휔푖) = 푁2(훽푖; 훽∗,Σ∗)퐼퐺(휙푖; 푎∗, 푏∗)퐵푒푟(푝푖; 푝∗)퐼퐺(휆푖; 휆∗)
Where, 휃푖 = (휆푖, 푝푖) are the parameters governing the local covariate distribution 푝(푋푖 ∣ 휃푖) = 푃표푖푠(퐿푖; 휆푖)퐵푒푟(퐴푖; 푝푖).
In the causal literature, the parameters of퐺0 (superscripted with asterisks above) are often set using empirical Bayes principles
while a relatively flat 퐺푎푚푚푎(1, 1) hyperprior is set on 훼. Specifically, 훽∗ might be set to the ordinary least squares estimates,
and Σ∗ may be set using the MLE covariance estimate. Empirical Bayes is a practical method of setting priors here as cross-
validation would be too computationally intensive. Moreover, we typically have no substantive knowledge that could guide these
choices. Centering the priors around empirical estimates also helps constrain the parameter draws to a reasonable range of the
observed data. Simulation studies in a variety of scenarios show that this tends to yield adequate frequentist properties (i.e.
credible intervals and point estimates with close to nominal coverage and bias, respectively, in repeated samples)28,29,30. This
approach is similar to Zellner’s g-prior - an empirical Bayes prior popular in the Bayesian model selection literature31.
Relationship to Kernel Regression
In this section, we discuss how the DP regression can be viewed as a Bayesian compromise between a fully empirical kernel
regression and a parametric regression.
A kernel regression estimate for a point with covariate vector 푋 is simply a weighted average of all the observed outcome
values, each weighted by how “close” the vector 푋 is to each observed covariate. Specifically, denote the centered Gaussian
kernel as 퐾ℎ(푢) (i.e. this is the density of a Gaussian with zero mean and variance ℎ). The Gaussian kernel regression32 is
defined as
퐸̂[푌 ∣ 푋] =
푛∑
푖=1
푤푘푖 (푋)∫ 푌 ⋅퐾ℎ(푌 − 푌푖)푑푌 . (16)
Note that ∫ 푌 ⋅퐾ℎ(푌 − 푌푖)푑푌 = 푌푖 is just the Gaussian mean. The weights 푤푘푖 (푋) are given by
푤푘푖 (푋) =
퐾푔(푋 −푋푖)∑
푖퐾푔(푋 −푋푖)
. (17)
Now taking 훼 → 0 (corresponding to an improper, flat prior) in the DP regression (13) yields
퐸[푌 ∣ 푋,휔(푚)1∶푛, 퐷] =
푛∑
푖=1
푤(푚)푖 휇
(푚)
푖 (푋), (18)
with limiting weights
푤(푚)푖 =
푝(푋 ∣ 휃(푚)푖 )∑
푖 푝(푋 ∣ 휃
(푚)
푖 )
. (19)
Comparing these equations, it is clear that the improper extreme of the DP regression becomes a type of kernel regression. In
particular, if we set 푝(푋 ∣ 휃푖) to be Gaussian with mean푋푖 and variance 푔 and set 휇(푚)푖 (푋) = 푌푖, then the DP regression reducesto a kernel regression estimate. Both models are covariate-weighted mixtures of subject level conditional mean models, though
the DP model is more satisfying from a statistical point of view. It outputs full posterior distribution over the regression. The
kernel regression typically produces a point estimate, with uncertainty estimation being more complicated. Moreover, with the
DP we can specify a covariate model, 푝(푋 ∣ 휃푖), that respects the support of the various covariates. This is in contrast to the
kernel regression, which uses a single kernel for the whole vector.
On the other extreme, take 훼 >> 푛. Then, the DP regression becomes 퐸[푌 ∣ 푋,휔(푚)1∶푛, 퐷] ≈ 푤(푚)0 휇(푚)0 (푋). Recall here that 휇0is the regression with parameters drawn from the prior 훽0 ∼ 퐺0. The weights 푤0 are also based on covariate parameters drawn
from the prior 휃0 ∼ 퐺0. In other words, this extreme results in a completely parametric model with parameters drawn from the
prior base disstribution. So we can view the DP regression as a type of posterior compromise between the kernel regression on
one extreme and a parametric regression on the other. It would also be fair to say that the DP regression is a regularized version of
the kernel regression. This perspective offers more insight into the role the hyperparameters of the local outcome and covariate
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distributions. Specifically, if 푝(푋 ∣ 휃푖) and 푝(푌푖 ∣ 푋푖, 훽푖, 휙푖) are Guassian, then the variance parameters of these distribution
play the same role as ℎ in the Kernel regression. Here, ℎ controls the bias-variance tradeoff. Large values of ℎ lead to a less
flexible (more penalized) fit, while small values of ℎ lead to more flexible (less penalized) fit. Similarly, prior distributions on
the variance parameters of these distributions that favor small values will yield a more flexible fit with less shrinkage.
Computing Causal Effects
The MCMC scheme involves obtaining posterior draws of {휔(푚)1∶푛}1∶푀 , which we can use to construct the mean regression
휇(푚)푖 (퐴,퐿) at each iteration. Under 퐼퐴.1 − 퐼퐴.4, we can estimate causal contrasts such as Ψ = 퐸[푌 1 − 푌 0] by integratingthis regression over the confounder distribution, just as in the parameter setting. Here, integration is done over a BB draw as in
Section 3.3,
1. Sample from the DP posterior to get
휇(푚)푖 (퐴,퐿)
2. Draw BB weights
푝(푚)1∶푛 ∣ 푊 ∼ 퐷푖푟(11∶푛)
3. Integrate to get posterior draw of Causal Effect:
Ψ(푚) ≈
푛∑
푖=1
푝(푚)푖
{
휇(푚)푖 (1, 퐿푖) − 휇
(푚)
푖 (0, 퐿푖)
}
The computationally demanding portion of the above is Step 1 and can be done using off-the-shelf R packages such asChiRP30.
This package runs the DP model in (12) and, by default, specifies local Gaussian distributions for non-binary and local Bernoulli
distributions for binary covariates. Figure 4 visualizes predictions trained using ChiRP, where the conditional outcome distri-
bution is simulated from a mixture of two damped harmonic oscillators. It also plots the ATE posterior from the DP model,
computed as described above. The ATEs are computed using a synthetic data set with a binary treatment and single Gaussian
confounder. In this example, the true treatment effect is a quadratic function of퐿. The figure also displays ATEs from a frequen-
tist linear additive model,퐸[푌 ∣ 퐴,퐿] = 훽0+훽1퐴+훽2퐿, estimated using OLS. These results are biased in this scenario. Detailed
descriptions of the synthetic example used for ATE computations in Appendix E. This appendix also contains implementation
of the ATE computation using ChiRP.
Survey of Recent DP Applications
The DP and related priors over random probability distributions such as the enriched DP33,34, dependent DP35,36, and centered
DP37 have also been applied to causal inference. For instance, Kim et al. (2017) employ a Dirichlet Process mixture to estimate
direct and indirect effects in a mediation analysis22. They specify a joint Gaussian model for the outcome, mediator, and con-
founders, and place a DP prior on the mean vector and covariance matrix. Later work applied DPs to latent mediators38. Roy et
al. (2018) use an enriched DP to model the joint distribution of the outcome and confounders, and estimate ATEs via posterior
standardization over the estimated distribution of the confounders29. They also describe posterior imputation of missing-at-
random covariates within their model. Roy et al. (2018) use a dependent DP to estimate a marginal structural model and apply it
to causal estimation with a survival outcome29. Xu et al. (2016) applied a similar dependent DP model to estimate causal effects
of dynamic treatment regimes39. Xu et al. (2018) propose an approach for estimating quantile causal effects (e.g. difference in
median outcome under one intervention versus another)40. A Bayesian Additive Regression Tree (BART) probit model is used
to to model the propensity score as a function of covariates, while a Gaussian outcome model is specified conditional on the
propensity score. The parameters of the joint outcome-propensity score model are given a DP mixture prior. We will describe
BART models in the next section. Oganisian et al. (2018) specify a generative model for the joint outcome, propensity score,
and confounder distribution, where the conditional outcome model is a two-part zero-inflated model41. The parameters of this
joint are given a DP mixture prior. Posterior standardization was conducted and a method for posterior predictive checks of pos-
itivity (퐼퐴.4) are proposed. Others42 have applied DP models to adjust for post-treatment variables via principal stratification43.
Centered DPs have also been used to estimate heterogeneous treatment effects44. Here, the centered DP was used as a prior for
an unspecified error term distribution of an accelerated failure time model.
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6.2 Bayesian Additive Regression Trees
The original BART approach of Chipman et al.45 models the conditional outcome distribution as a Gaussian with mean function
휇(푋) =
퐽∑
푗=1
푔(푋; 푇푗 ,푀푗) (20)
Above, the conditional mean is modeled as a sum of predictions from 퐽 regression trees, 푇푗 . In this sense BART can be viewed
as an ensemble learner. Specifically, 푇푗 consists of a set of nodes and splitting rules with an associated vector of terminal node
parameters푀푗 . The function 푔 maps covariates 푋푖 to one of the terminal node parameters in푀푗 . The mean is then the sum of
the terminal node predictions from each of the trees. The BART prior, consisting of priors on the splitting rules and terminal
node parameters, is formulated to induce shrinkage towards shallow trees. This helps prevent over-fitting. This serves as a
probabilistically principled alternative to pruning heuristics often used with random forests. Predictions for a toy examples are
given in Figure 4. Notice that BART produces a step function as a result of the the assumed tree structure of 휇(푋). This holds
even as BART interpolates across the covariate space with no training data (the red points in the plot indicate held out test data).
The MCMC inference engine behind BART relies on the “backfitting”46 approach, which takes posterior draws of each tree
structure and their terminal node parameters sequentially. Each tree is fit using the residual from the previously fit trees as the
outcome. At every iteration 푚, one such cycle through the 퐽 trees yields 푇 (푚)푗 and푀 (푚)푗 , which we can then use to construct aregression
휇(푚)(퐴,퐿) =
퐽∑
푗=1
푔(퐴,퐿; 푇 (푚)푗 ,푀
(푚)
푗 )
We can use existing software in R such as BayesTree to obtain the posterior draws for 휇(푚)(퐴,퐿) under both interventions.
We first stack two test data sets 퐷푎푡푒푠푡 = (퐴 = 푎, 퐿푖)1∶푛 for 푎 ∈ {0, 1} into a single test set {퐷1푡푒푠푡, 퐷0푡푒푠푡}. The training datasimply consists of the observed data set 퐷푡푟푎푖푛 = (푌푖, 퐴푖, 퐿푖)1∶푛. The package will then output BART estimates of 휇(푋) under
both interventions in the stacked test set {휇(푚)(1, 퐿푖), 휇(푚)(0, 퐿푖)}1∶푛 for 푚 = 1,…푀 . To compute the integral in (1), we can
post-process the draws in R as follows. For each iteration, take a BB draw 푝(푚)1∶푛 and compute
Ψ(푚) =
푛∑
푖=1
푝(푚)푖
(
휇(푚)(1, 퐿푖) − 휇(푚)(0, 퐿푖)
)
In this way we obtain draws from the posterior of the ATE. Our review of BART was cursory, with a focus on causal estimation.
We refer the reader to Tan et al. (2019) for a thorough tutorial on BART and its various extensions47.
Survey of Recent BART Applications
We now provide a brief (but by no-means exhaustive) survey of BART in interesting causal inference applications. Hill (2011)
first applied BART to ATE estimation48. BART has since enjoyed wide popularity in causal estimation. For instance, it has
been used to formulate fully Bayesian semi-parametric estimation of structural mean models49, fully nonparametric estimation
of optimal dynamic treatment regimes50, and estimation of causal effects in the presence of positivity violations51. The latter
augments BART with splines to extrapolate to regions of the data with deterministic treatment (i.e. non-overlap regions). Work
by Hahn et al. (2017) has focused on improving the use of BART for causal inference52. They separate out the the treatment and
confounder effects in the outcome regression, which aims to improve bias due to what the authors term “regularization-induced
confounding”.We also note that the original BARTmodel presented here has been extended for outcomes with different support.
For instance, the mean function modeled using BART can be run through a probit link when the outcome is binary. Sparapani
et al. proposed using BART for survival outcomes53. They use a discrete-time failure model where the probability of death at
each time point is modeled with a BART probit.
6.3 Gaussian Process (GP) Models
Here we review another BNP approach using Gaussian process (GP) priors for regression modeling54,55. Although less widely
used in the causal literature relative to DP and BART models, GPs are popular in the BNP literature. They can be implemented
in Stan and so may be a practical choice for applied researchers. We consider the same problem of modeling, 휇(푋), the mean
function of a Gaussian outcome, 푌 ∣ 푋 ∼ 푁(휇(푋), 휙). The GP can bemotivated as a prior over the space of regression functions,
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휇(푋). We say that 휇(푋) follows a GP with prior mean function 휃0(푋) and covariance 푪(푋; 휂, 휌). Together with the full model,
this is denoted as
푌 ∣ 휇(푋) ∼ 푁
(
휇(푋), 휙
)
휇(푋) ∼ (휃0,푪). (21)
Above we have suppressed dependence of 휃0 and 푪 on 푋 and hyperparameters (휂, 휌) for compactness. Our prior belief is that
the regression function 휇(푋) is randomly distributed around some mean regression function 휃0, with linearity and smoothness
of 휇(푋) relative to 휃0 being controlled by the hyperparameters. For example, a common prior mean function choice is 휃0(푋) = 0
- a hyperplane through the origin. Another, approach is to set 휃0(푋) = 푋′훽. The latter specification centers our prior around
a linear/additive prior mean regression function, while 휂 and 휌 allow for deviations from this prior if the data are inconsistent.
The covariance can have many specified forms, but we focus on the exponential-quadratic form popular in the causal literature,
푪푖푗 = 휂 exp{−휌||푋푖 −푋푗||2} + .01훿푖푗 , (22)
where ||푣|| = √푣′푣 denotes the 퐿2 vector norm. 푪 is the 푛 × 푛 matrix with elements given by 푪푖푗 . Intuitively, this describes
the prior belief that the regression function evaluations should be similar for two subjects with similar covariate vectors. The
evaluations should differ more for two subjects who have very different covariates. The parameter 휌 controls how similar these
function evaluations are for subjects with similar covariates. Larger 휌 favors more similar regression evaluations. The parameter
휂 controls the linearity of the regression function - with smaller 휂 penalizing non-linearity and a priori favoring linear regression
functions.
Stan can be used to sample from the posterior distribution of the regression function 휇(푋). Specifically, it outputs푀 draws
from the posterior of the regression function {휇(푚)(푋)}1∶푚. These posterior draws are visualized in Figure 4 for both training
and held-out test points. Causal ATE estimation can be done by feeding Stan two held-out test data sets, 퐷푎푡푒푠푡 = (푎, 퐿푖)1∶푛for 푎 ∈ {0, 1}. This returns posterior draws the regression function under both interventions {휇(푚)(1, 퐿푖), 휇(푚)(0, 퐿푖)}1∶푛 for
푚 = 1,…푀 . Within Stan, standardization can be done using BB as described before. For each iteration, take a BB draw 푝(푚)1∶푛and compute
Ψ(푚) =
푛∑
푖=1
푝(푚)푖
{
휇(푚)(1, 퐿푖) − 휇(푚)(0, 퐿푖)
}
Posterior inference for the ATE using this GP model is shown in Figure 4. Implementation details for this synthetic example
are given in Appendix E. Finally, we note that GPs can easily accommodate outcomes with non-continuous/real support. For
instance, with count outcomes we could specify 푌 ∣ 푋 ∼ 푃표푖푠
(
exp(휇(푥))
)
. Here, we model log(퐸[푌 ∣ 푋]) = 휇(푋) and place
a GP prior on 휇(푋) as in the Gaussian case.
Recent Applications in Causal Inference
Gaussian process priors have seen some usage in the causal literature. For instance, the dependent DP, used for posterior inference
about marginal structural models29 and dynamic treatment regimes39 is essentially a combination of the DP and GP. Specifically,
each cluster-specific regression function in the DP is assigned a GP prior. Just as the Guassian local model in (12) induced
a posterior regression that is a mixture of linear regression functions, the dependent DP induces a posterior regression that
is a mixture of GP regression functions. Other uses of GPs included modeling pollution outcomes in the presence of spatial
interference (i.e. violations of 퐼퐴.3 that exhibit spatial structure)56 and estimation of propensity scores57.
7 DISCUSSION
In this paper we reviewed causal effect estimation from a Bayesian perspective in point-treatment and time-varying treatment
settings. For the latter, we outlined how to estimate causal effects of both static and dynamic treatment regimes. Both parameteric
and nonparametric settings were discussed. Along the way, we discussed the utility of priors both for providing interpretable
shrinkage and also for conducting causal sensitivity analyses. Throughout, we emphasize that the ad-hoc procedures we often use
correspond to strongly informative priors. Throughout, we have highlighted various BNP techniques used for causal estimation
in the literature. We hope that these surveys will be useful literature overviews that can serve as a starting point for those who
want to delve further into these methods.
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We note that our treatment of Bayesian causal estimation differs from that of Rubin58 - which is fundamentally a finite-
sample approach. In this approach, each subject’s counterfactual is treated as a missing data point and the target is the posterior
distribution over these missing variables, 푝({푌 1−퐴푖푖 }1∶푛, ∣ 퐷). Here, 퐷 = {푌 퐴푖푖 , 퐴푖, 퐿푖}1∶푛 consists of the observed potentialoutcomes, treatment assignment, and confounder vector. Denote the parameters governing the observed data distribution as 휔.
By Bayes’ rule we can express the desired posterior as
푝({푌 1−퐴푖푖 }1∶푛, ∣ 퐷) = ∫ 푝({푌 1−퐴푖푖 }1∶푛, ∣ 휔)푝(휔 ∣ 퐷)푑휔
∝ ∫ 푝({푌 1−퐴푖푖 }1∶푛, ∣ 휔)푝(퐷 ∣ 휔)푝(휔)푑휔
Suppose that 푛1 of the 푛 subjects are treated. Then the likelihood is
푝(퐷 ∣ 휔) = 푝(푌 1푖 ,… , 푌
1
푛1
, 푌 0푛1+1,… 푌
0
푛 ∣ 퐿1∶푛, 휔)
Thus this approach requires a model for the joint distribution of 푝(푌 1, 푌 0 ∣ 퐿,휔), which is not identifiable in the data: we
never observe both potential outcomes for any subject. By non-identifiable, we mean that the posterior (even if it is proper)
over this joint distribution will be completely driven by the prior. This issue is not unique to Bayesian inference. For instance,
the variance of the sample average treatment effect is not identifiable from a frequentist perspective either59. It is a function
of the covariance of the two potential outcomes, which we cannot learn. Ding et al. (2018) provide an excellent review of
Bayesian causal inference from this missing data perspective60. This missing data approach is the central idea behind the more
recent PENCOMP method61, which uses a penalized splines to impute the missing counterfactuals. The approach described in
our paper is what Ding et al. (2018) term the “super-population” approach, rather than the finite-sample approach. This super-
population approach focuses on estimands that are a function of the parameters governing the data generation process. Once we
have a good model of the process, these estimands are simply transformations of these parameters.
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APPENDIX
A CAUSAL DOSE EFFECT EXAMPLE
A.1 Data generation and implementation in Stan
This appendix provides a more detailed walkthrough of the synthetic example and model discussed in Section 3.1. We refer the
reader to the Stan manual online for details about the language, syntax, and best practices. The toy example was simulated as
follows. For 퐾 = 10 doese levels 푘 ∈ {0,… , 9}, and 푛 = 100 subjects, indexed by 푖 we simulate:
1. single continuous confounder:
퐿푖 ∼ 푁(0, 1)
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2. treatment assignment:
퐴푖 ∣ 퐿푖 ∼ 푃 (퐴푖 = 푘) ∝ expit(1 − (2∕9) ⋅ 푘 + 퐿푖 − .5푘퐿푖)
3. outcome:
푌푖 ∣ 퐴푖, 퐿푖 ∼ 푁(5 ⋅Φ(퐴푖 − 5) − 5 ⋅ 퐿푖, 2)
Above, Φ(⋅) is the standard normal CDF. Notice that the baseline probability of treatment decreases with dose level. Reflecting
a realistic scenario where fewer patients are likely to be assigned to higher doses. The confounder 퐿푖 impacts both treatment and
the outcome. Higher values of 퐿푖 make higher dose assignments more likely (note the −.5푘퐿푖 term). At the same time, higher
퐿푖 lead to lower outcomes. This simulation takes place in the first several lines of dose_response.R in the GitHub repository.
The logic behind using Φ is purely to have an interesting/realistic toy example. 퐴 = 5 is about the middle dose level. Using
Φ we are ensuring that doses much higher than the middle have diminishing returns on the outcome. Each dose increase affects
the outcome less and less. Thus the true dose effect curve is 5 ⋅Φ(퐴−5), which is plotted in red in Figure 1a. We need to adjust
for 퐿푖 because patients with higher 퐿 are more likely to be treated at all levels and less likely to have higher outcomes.
The full probability model is
푌푖 ∣ 퐴푖, 퐿푖 ∼ 푁(휇(퐴푖, 퐿푖), 휙)
Where, 휇(퐴푖, 퐿푖) is the conditional expectation in (3) - a function of 휃0∶퐾 and 훽. In the paper we discussed the priors on 휃1∶퐾 .
These took the form of a sequence of dependent Gaussian priors, as a function of 휇 and 휏푘. This likelihood is specifying in the
”model” block of the Stan code DR_model.stan:
model {
// specify priors
theta[1] ~ normal( 0, 10 );
theta[2] ~ normal( 2*theta[1], 1);
for(j in 3:num_A_levels){
theta[j] ~ normal( 2*theta[j-1] - theta[j-2], 1 );
}
beta ~ normal(0, 10);
phi ~ cauchy(0,10);
// specify likelihood
Y ~ normal(L*beta + A*theta , phi);
}
Note that in the above, an intercept is included in 퐿. Notice here we have set 휇 = 0, 휏1 = 10, and 휏1∶퐾 = 1. We specify a
Gaussian prior with standard deviation (SD) 10. This is a relatively flat prior since this SD is larger than the sampling model
SD= 2. On 휙 we place a half-Cauchy prior with scale 10 - again, fairly flat. If we wanted to place priors on, say, 휇 instead of
setting it at 휇 = 0, we could have instead specified
model {
// specify priors
mu ~ normal(0, 10);
theta[1] ~ normal( mu, 10 );
...
}
We would also need to declare 휇 in the “parameters” block of DR_model.stan. The same idea holds for 휏0∶퐾 . We could also
specify hyper-prior distributions for these variables. We fix these to constant values for simplicity of the illustrated examples
and to maintain focus on the AR1 prior construction. Another important portion of DR_model.stan worth highlighting is the
“generated quantities” block. In this block, we can perform post-processing of posterior draws of parameters. For instance, we
can post-process draws of 휃1∶퐾 to compute the curve Ψ(푘):
generated quantities {
vector[num_A_levels] Psi;
Psi[1] = theta[1];
for(k in 2:num_A_levels){
Psi[k] = theta[k] - theta[k-1];
}
}
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Above, we declare a vector of length num_A_levels (which is 퐾 = 10 in this example). And compute Ψ(푘) = 휃푘 − 휃푘−1 as
defined in the main text. In dose_response.R we call the Stan model using the rstan package - which allows us to call Stan
programs fromR. Using theR function stan_model(), we compile the Bayesian model specified in DR_model.stan. Using theR
function sampling() we take 500 posterior draws after a 500 draw burn-in period. Only one chain is run. In practice, more chains
should be used with more posterior draws and a longer burnin period. We should check that the chains for Ψ in the generated
quantities block has converged. Posterior predictive checks should also be done to evaluate model fit. Guidance for convergence
and posterior predictive checks is no different in this causal setting than in the general Bayesian modeling framework, so we
leave details to standard Bayesian texts such as Bayesian Data Analysis14.
A.2 Implementation in SAS
The file dose_analysis.sas in our companion GitHub repository repeats the analysis above using PROC MCMC in SAS. Within
PROC MCMC, we use the “parms” statement to declare the parameters of our model. In this case, we declare the dispersion
parameter “phi”, the nine conditional dose effects ( t1, t2, ..., t9), the confounder effect ( “bL” ), and the intercept (“b0” ):
parms phi t1-t9 bL b0;
The AR1 prior can be specified using the “prior” statement:
prior t1 ~ normal(0, sd=10);
prior t2 ~ normal(2*t1, sd=1);
prior t3 ~ normal(2*t2 - t1, sd=1);
prior t4 ~ normal(2*t3 - t2, sd=1);
prior t5 ~ normal(2*t4 - t3, sd=1);
prior t6 ~ normal(2*t5 - t4, sd=1);
prior t7 ~ normal(2*t6 - t5, sd=1);
prior t8 ~ normal(2*t7 - t6, sd=1);
prior t9 ~ normal(2*t8 - t7, sd=1);
The Gaussian likelihood is specified using the “model” statement:
muA = t1*A1 + t2*A2 + t3*A3 + t4*A4 + t5*A5 + t6*A6 + t7*A7 + t8*A8 + t9*A9;
model Y ~ normal( b0 + muA + bL*L , sd=phi);
Finally, for computational efficiency, we can compute the causal effects of interest directly within PROC MCMC as simple
transformations of t1, t2, ...t9 after specifying the likelihood. Note this is completely analogous to the generated quantities block
in Stan.
Psi[1] = t1 ;
Psi[2] = t2 - t1;
Psi[3] = t3 - t2;
Psi[4] = t4 - t3;
Psi[5] = t5 - t4;
Psi[6] = t6 - t5;
Psi[7] = t7 - t6;
Psi[8] = t8 - t7;
Psi[9] = t9 - t8;
Overall, the results from SAS are quite similar to results in Stan.
B CONDITIONAL CAUSAL EFFECTS
B.1 Data generation and implementation in Stan
This appendix walks through simulation and analysis of the synthetic example discussed in Section 3.2, including imple-
mentation of the Bayesian bootstrap in Stan. The synthetic data was simulated for 푛 = 500 subjects (indexed here by 푖) as
follows:
1. Confounder푊푖 ∼ 푁(0, 1).
2. Stratum membership, 푉푖, with probability 푃 (푉푖 = 푣) = 푝푣 for 푣 ∈ {1, 2,… , 5}. Where we set
푝1∶푣 = (
3
10
, 3
10
, 2
10
, 1
10
, 1
10
)
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3. Treatment assignment as Bernoulli with probability
푃 (퐴푖 ∣ 푊푖, 푉푖 = 푣) = expit(1 ⋅푊푖 + 훾푣)
Where 훾1∶5 = (0,−.5, .5, .5,−.5)
4. Scalar Bernoulli outcome with probability
푃 (푌푖 ∣ 퐴푖,푊푖, 푉푖) = expit[−1 +푊푖 + (1 +
5∑
푣=2
휂푣퐼(푉푖 = 푣))퐴푖]
Where 휂2∶5 = (−.5, 0, .5, .6) (푉 = 1 is the reference).
Again note that 푊푖 and 푉푖 both impact treatment probability and the outcome probability. The strata membership simulation
mirrors practical examples where some strata are more populated (i.e. with probability 3∕10) than other strata (i.e. with proba-
bility 1∕10). In the outcome model, notice that the conditional treatment effect varies with stratum membership. Motivating the
need for causal effect estimates conditional on each stratum. This simulation is done in the top portion of partial_pool.R.
The full probability model we specify for the outcome is that
푌푖 ∣ 퐴푖,푊푖, 푉푖 ∼ 퐵푒푟(휇(퐴푖, 퐿푖))
where 휇(퐴푖, 퐿푖) is the conditional expectation in (6), reproduced here with notation specific to this example
퐸[푌푖 ∣ 퐴푖, 퐿푖] = 휎
{
훾 + 훽푤푊푖 +
5∑
푣=2
훽푣퐼(푉푖 = 푣) + [휃1 +
5∑
푣=2
휃푣퐼(푉푖 = 푣)]퐴푖
}
Recall here that 휎{⋅} is the inverse logit link. Note here that 휃1 is the conditional (on푊 ) treatment effect in stratum 1 - which,
in this parameterization, is the reference stratum. Similarly, 휃1 + 휃푣 is the treatment effect in stratum 푣 for 푣 ∈ 2,… , 5.
The Bayesian model is specified in partial_pool.stan. Below, is the “model” block where we specify the prior in (7) and
likelihood. In the code, “W” is an 푛 × 1 matrix containing each subject’s confounder value and “V” is an 푛 × 5 matrix with 푖푡ℎ
row (1, 퐼(푉푖 = 2), 퐼(푉푖 = 3), 퐼(푉푖 = 4), 퐼(푉푖 = 5)). Thus, 퐼(푉푖 = 1) is the reference. The variable “theta” is a 5 × 1 vector, 휃1∶5.
The variable 훽푣 is a 5 × 1 vector of 푉 -specific main effects, 훽2∶5 including a constant ( 훾 in the model above ).
The prior for “theta” is specified to induce partial pooling as discussed. We set the standard deviation of the Gaussian priors
on 휃1∶5 to be 휏 = .5. A Gaussian hyper-prior is placed on 휇. Note that on a logit scale this is quite flat. A Gaussian prior is also
used on the coefficient of the confounder and intercept
model {
// specify priors
beta_w ~ normal(0, 1);
beta_v ~ normal(0, 1);
mu ~ normal(0, 1);
theta[1] ~ normal( mu, .5 );
theta[2:Pv] ~ normal( mu - theta[1], .5);
// specify likelihood
for(i in 1:N){
Y[i] ~ bernoulli_logit( W[i]*beta_w + V[i]*beta_v + ( V[i]*theta )*A[i] ) ;
}
}
As before in Appendix A, we can use the generated quantities block for post-processing. As discussed in the main manuscript,
this involves integrating the estimated model over a Bayesian bootstrap (BB) estimate of the conditional distribution of푊 ∣ 푉 ,
푃푣(푊 ). Below, we include an excerpt from partial_pool.stan that loops through each stratum of 푉 and computes a causal odds
ratio for that stratum. Below, we compute the conditional mean outcome under intervention 퐴 = 1 and 퐴 = 0 for each subject:
cond_mean_y1 and cond_mean_y0, respectively. Then we take a weighted average of these conditional means, with bootstrap
weights coded as bb_weights. Here, the Stan function dirichlet_rng takes a draw from 퐷푖푟(1푛푣), which is the BB posteriorestimate of 푃푣(푊 ). This weighted average is an estimate of themarginalmean under each intervention, coded as marg_mean_y1
and marg_mean_y0. Computing the odds ratio is done as usual using these marginal means.
generated quantities {
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real marg_mean_y1;
real marg_mean_y0;
real odds_1;
real odds_0;
...
// cycle through strata of interest and compute causal Odds Ratio for each.
vector[Pv] odds_ratio;
for( v in 1:Pv ){
// n_v = number of subjects in that stratum
// v_start:v_end are the row indices of subjects in stratum V
int nv = n_v[v];
int v_start = ind[v]+1;
int v_end = ind[v+1];
vector[nv] cond_mean_y1;
vector[nv] cond_mean_y0;
vector[nv] bb_weights;
// subset to stratum v
matrix[nv, Pw] Wv = W[ v_start:v_end, ];
matrix[nv, Pv] Vv = V[ v_start:v_end,];
// compute conditional means.
cond_mean_y1 = inv_logit( Wv*beta_w +Vv*beta_v + Vv*theta );
cond_mean_y0 = inv_logit( Wv*beta_w + Vv*beta_v );
// Bayesian bootstrap weights for P_v(W)
bb_weights = dirichlet_rng( rep_vector(1, nv) ) ;
// taking average over bayesian bootstrap weights under both treatments
marg_mean_y1 = bb_weights’ * cond_mean_y1;
marg_mean_y0 = bb_weights’ * cond_mean_y0;
// compute odds ratio
odds_1 = (marg_mean_y1/(1 - marg_mean_y1));
odds_0 = (marg_mean_y0/(1 - marg_mean_y0));
odds_ratio[v] = odds_1/odds_0;
}
...
}
In the sampling statement in partial_pool.R, we run a single sampling chain consisting of 1000 posterior draws after 1000
burnin draws. The results of this computation is shown in Figure 1b, which is potted in partial_pool.R.
B.2 Implementation in SAS
The code partial_pool.sas in our companion GitHub repository repeats the analysis in SAS. The main procedures involved are
PROC MCMC (as in the dose effect example) and PROC IML. Here, PROC IML (Integrated Matrix Language) is used to
manipulate the posterior draws obtained from PROCMCMC and conduct the Bayesian Bootstrap. Since the PROCMCMC step
is very similar to the dose effect example, here we focus on the PROC IML post-processing step.
The first statements in PROC IML load in two datasets as matrices. First, dataset “posterior_draws” is loaded and stored as
matrix “pm”. This is a matrix with each column corresponding to a parameter and each row corresponding to a posterior draw.
This was an output from PROC MCMC. Second, dataset “mcmc_data” is loaded and stored as matrix “X”. This is the model
matrix with 푛 rows (for each of the 푛 subjects) and covariates along the columns. Here is the relevant excerpt:
/* Read in matrix of posterior draws from SAS to IML */
use posterior_draws; read all var _ALL_ into pm; close posterior_draws;
/* Read in model matrix from SAS to IML */
use mcmc_data; read all var _ALL_ into X; close mcmc_data;
n = nrow(X);
n_iter = nrow(pm);
/* shell to store posterior draws of Causal OR for each of the 5 strata */
OR_mat = j(n_iter, 5, 0);
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Next, we loop through each posterior draw, indexed by “i” in the code. For each draw, we loop through the strata of 푉 , take a BB
draw of the conditional confounder distribution 푃푣(푊 ), and integrate the logistic model over this BB draw of the conditional
confounder distribution to attain the marginal means under each treatment. The odds ratio is computed in terms of these means.
Here is the relevant excerpt:
do v = 1 to 5;
/*X[,6] is the column containing V_i. */
nv = sum(X[,6] = v); /* Find how many subjects in stratum v */
idx = loc(X[,6] = v) ; /* find which obs are in stratum v */
/* Draw from Dirichlet(1_{nv}) distribution
to do bayesian bootstrap estimate of P_v(W) */
alpha= J(nv , 1 , 1);
bb_w = RandDirichlet(1, alpha);
bb_w = bb_w || 1-sum(bb_w);
/* for each strata, compute logit of event
under treatment 1 and 0: lp1, lp0*/
/* compute reference group v=1 separately */
if v=1 then do;
lp1 = pm[i,2] + pm[i, 3]*X[ idx , 8] + pm[i, 8] ;
lp0 = pm[i,2] + pm[i, 3]*X[ idx , 8] ;
end;
if v>1 then do;
lp1 = pm[i,2] + pm[i, 3]*X[ idx , 8] + pm[i,2+v] + (pm[i, 8] + pm[i,7+v] ) ;
lp0 = pm[i,2] + pm[i, 3]*X[ idx , 8] + pm[i,2+v] ;
end;
/* inverse logit transform to convert to probability */
p1 = exp(lp1)/(1+exp(lp1));
p0 = exp(lp0)/(1+exp(lp0));
/* bayesian bootstrap average of probability*/
/* dot-product: bb_w is 1-X-n vector and p1, p0 are n-X-1 */
mu1 = bb_w*p1;
mu0 = bb_w*p0;
/* compute Odds Ratio for stratum v */
OR_mat[i,v] = ( mu1/(1-mu1) ) / ( mu0/(1-mu0 ) ) ;
end;
Note that indexing of “pm” and “X” is so that we grab the appropriate columns of the model matrix and posterior parameters
when forming the log odds ratio as a linear combination of these parameters. This is completely analogous to the “generated
quantities” block in the Stan implementation. The SAS results are quite similar to results in Stan. Since we run relatively few
MCMC iterations with different seeds across statistical software, some small differences are expected.
C PRIORS ON SENSITIVITY PARAMETERS
C.1 Implementation in Stan
Here, we briefly describe using the generated quantities block in Stan to conduct the sensitivity analysis described in Section
5. The synthetic example underlying Figure 3b was simulated as follows in the program sensitivity.R. For 푖 = 1,… , 푛 = 100
subjects,
1. Simulate two confounders 퐿푖 ∼ 푁(0, 1) and 푈푖 ∼ 푁(0, 1).
2. Simulate treatment assignment 퐴푖 from a Bernoulli with probability
푃 (퐴푖 = 1 ∣ 퐿푖, 푈푖) = expit(퐿푖 + 푈푖)
3. Simulate outcome 푌푖 from
푌푖 ∣ 퐴푖, 퐿푖, 푈푖 ∼ 푁(퐴푖 − 퐿푖 − 2푈푖, 1)
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Notice here that subjects with higher 푈푖 are more likely to be treated and have lower outcome values. Failing to adjust for 푈푖
may lead us to conclude that the treatment effect is negative, while in reality is is positive (specifically, treatment has coefficient
+1 in the conditional outcome model).
We specify the following misspecified Bayesian model where 푈푖 is excluded:
푌푖 ∣ 퐿푖, 퐴푖 ∼ 푁(휃퐴푖 + 훽퐿푖, 휙)
As described in the introduction, the ATE produced by standardization from this linear conditional mean model is simply 휃.
However, Posterior estimates of 휃 will be biased since we did not adjust for some unmeasured confounder 푈푖 (i.e. 퐼퐴.1 is
violated). Here, we perform the sensitivity analysis described in Section 5. In the model block of sensitivity.stan, we specify the
model as shown in the following excerpt
model {
// set priors
theta ~ normal(0, 3);
beta ~ normal(0, 3);
delta1 ~ normal(0,1/sqrt(3));
// specify likelihood
Y ~ normal(A*theta + beta*L, phi);
}
Notice that the sensitivity parameter here is coded as delta1 and given a standard Gaussian distribution. Now, in the generated
quantities block, we compute the perturbed estimate of the ATE, coded as psi3.
generated quantities {
...
real psi3;
...
psi3 = theta + delta1;
}
This produces the posterior estimates for Δ ∼ 푁(0, 3−1∕2) in Figure 3b. Note ellipses here denote ommitted code. The full code
is available in the companion GitHub repository.
C.2 Derivation of Bias
Here we detail the derivation of the bias, 휉. Define the amount of bias in potential outcome 푌 푎 as
Δ푎(퐿) = 퐸[푌 푎 ∣ 퐴 = 1, 퐿] − 퐸[푌 푎 ∣ 퐴 = 0, 퐿]
Now, take 퐸[푌 푎]. Iterate expectation over 퐿 and then iterate once more over 퐴, conditional on 퐿. We get
퐸[푌 푎] = ∫ 퐸[푌 푎 ∣ 퐴 = 0, 퐿] + Δ푎(퐿)푒(퐿) 푑푃 (퐿)
Noting that 퐸[푌 1 ∣ 퐴 = 0, 퐿] = 퐸[푌 1 ∣ 퐴 = 1, 퐿] −Δ1(퐿) (by definition of Δ1(퐿)), we have the following expressions for each
expected potential outcome
퐸[푌 0] = ∫ 퐸[푌 0 ∣ 퐴 = 0, 퐿] + Δ0(퐿)푒(퐿) 푑푃 (퐿)
and
퐸[푌 1] = ∫ 퐸[푌 1 ∣ 퐴 = 1, 퐿] − Δ1(퐿)(1 − 푒(퐿)) 푑푃 (퐿)
Note that consistency allows us to drop the superscripts 푎 when conditioning on 퐴 = 푎 so that 퐸[푌 푎 ∣ 퐴 = 푎, 퐿] = 휇(푎, 퐿) .
Then subtracting yields,
퐸[푌 1 − 푌 0] = ∫ 휇(1, 퐿) − 휇(0, 퐿)푑푃 (퐿) −
{
∫ Δ1(퐿)(1 − 푒(퐿)) + Δ0(퐿)푒(퐿) 푑푃 (퐿)
}
Thus, under this ignorability violation, the target is equal to the usual standardization (first term on the right of the equal sign)
having subtracted off the bias (the second term, which we define as 휉 in the main text).
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D TIME-VARYING TREATMENTS
In the companion GitHub repository, the programs g_comp.R and gcomp.stan simulate the synthetic example and produce the
posterior inference behind Figure 3a. Simulating and coding the analyses in this multi-time point setting is a little more tedious
- involving more Stan syntax. We leave the details to the code comments. Briefly, the synthetic example contains a single binary
treatment, time-varying confounder, and outcome for 10 time points. The confounder at each time point is simulated from a
Gaussian with a conditional mean being a function of all previous confounder values. Treatment at each time point is simulated
from a Bernoulli with probability being a function of all previous confounder and treatment values. Lastly, a single outcome at
the end is simulated from a Gaussian with conditional mean being a function of all previous treatment and confounder values.
The generated quantities block demonstrates how we can simulate confounders sequentially conditional on “always treated”
and “never treated” regimes. This is the type of simulation requires to compute ATEs of both static and dynamic treatment
regimes outlined in the main text.
E NONPARAMETRIC MODELS
This Appendix will focus on implementation details behind Section 6 - specifically the computation of ATEs in panel d of Figure
4. We will cover implementation of DP mixtures and BART in R packages ChiRP and BayesTree, respectively, as well as GP
models in Stan that are contained in the program npbayes_ATE.R available in the companion GitHub repository. The synthetic
data behind this example was simulated as follows. For 푖 = 1, 2,… , 푛 = 500 subjects,
1. Simulate confounder 퐿푖 ∼ 푁(0, 1).
2. Simulate treatment assignment, 퐴푖, from Bernoulli with probability
푃 (퐴푖 ∣ 퐿푖) = expit(1 −
1
2
퐿푖)
3. Simulate outcome, 푌푖, as
푌푖 ∣ 퐴푖, 퐿푖 ∼ 푁
(
(퐿푖 +
1
2
퐿2푖 )퐴푖 ,
1
5
)
Note above that the conditional treatment effect is a parabolic function of 퐿푖. This is a complex function form. Note that the true
causal effect via standardization is:
Ψ = 퐸퐿[퐸[푌 |퐴 = 1, 퐿] − 퐸[푌 |퐴 = 0, 퐿]]
= 퐸퐿[퐿푖 +
1
2
퐿2푖 ]
= 퐸퐿[퐿푖] +
1
2
퐸퐿[퐿2푖 ]
= 1
2
The last line follows from the fact that 퐿 has a standard normal distribution. A parametric model will only recover this effect
if it correctly specified - a tall order for such a complex functional form. Instead, Section 6 illustrates several nonparametric
approaches.
Implementation of the model in (12) can be done via the fDPMix() funciton in ChiRP. We refer the reader to the companion
web site1 and R help documentation for detailed information on defaults. The simulated data set is stored in an R object called
d_train in npbayes_ATE.R. Recall that we want posterior draws of the conditional outcome mean, for each subject, under both
interventions. To that end, we construct the dataset d_test as follows:
d_a1 = data.frame(A=1, L=d_train$L)
d_a0 = data.frame(A=0, L=d_train$L)
d_test = rbind(d_a1, d_a0)
Note that d_test is the observed data set stacked twice: once with treatment set to 1 for all subjects, another with treatment
set to 0 for all subjects. This will allow us to obtain predictive draws for each subject under both interventions. We now feed
1https://stablemarkets.github.io/ChiRPsite/index.html
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these data sets into fDPMix() function and specify that the conditional mean outcome model to be a function of 퐿 and 퐴. We
take 500 posterior draws after a 500 draw burnin. Initial number of clusters is set to 10. In practice, several chains with various
initializations should be run and checked for mixing.
set.seed(2)
res=fDPMix(d_train = d_train, formula = Y ~ L + A,
d_test = d_test,
iter=1000, burnin=500, init_k = 10)
The object res is a list containing a 2푛× iter-burnin matrix where the first 푛 rows are posterior predictions for each subject
under treatment 퐴 = 1 and the next 푛 rows, from 푛 + 1 to 2푛, are posterior predictions under treatment 퐴 = 0. The program
npbayes_ATE.R has a short function called bayes_boot() that performs BB standardization using these draws, as described in the
test. The result is a length iter-burnin vector of posterior draws for the ATE. Additional confounders can be handled accordingly.
The other nonparametric models are implemented very similarly. In the same R program, we have implemented BART using
the BayesTree package as:
bart_res = bart(x.train = d_train[, c(’L’,’A’) ],
y.train = d_train$Y, x.test = d_test,
ndpost = 500, , nskip = 500)
Here, we take 500 posterior draws after a 500 period burn-in. Again, we stress that in practical examples, longer burnin will
likely be required. By default, this implementation runs BART using a sum of 200 trees. The function can accomodate other
prior settings. We refer the reader to the R documentation.
The implementation of the GP regression was taken directly from the Stanmanual section on Gaussian Processes2 with some
minor modifications. We leave implementation details to our code and the online manual. It is quite similar to the parametric
Stan implementations discussed in earlier appendices. Stan uses the following parameterization of the exponential-quadratic
covariance function:
푪푖푗 = 훼2 exp
(
− 1
2휖2
||푋푖 −푋푗||2)
The parameter 휂 in the main manuscript corresponds to 훼2, while the parameter 휌 in the manuscript corresponds to
1
2휖2
above. In Stan, we can conduct posterior inference on the hyperparameter by assigning them priors. In the program
gaussian_process_with_HPs_multi.stan this is done in the model block. Here is the relevant excerpt:
model {
...
rho ~ inv_gamma(5, 5);
alpha ~ std_normal();
...
}
Here since 훼 is declared to be be a non-negative parameter, the specified standard normal prior defaults to a half-normal prior.
2https://mc-stan.org/docs/2_22/stan-users-guide/fit-gp-section.html
